(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of CTNNB1 protein CTD PMID:12387456 (-)-demecolcine increases expression ISO RGD:733705 6480464 Demecolcine results in increased expression of CTNNB1 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:733705 6480464 epigallocatechin gallate results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:16968065 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1550466 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:27058323 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1550466 6480464 epigallocatechin gallate results in decreased expression of CTNNB1 protein CTD PMID:12351151 (-)-epigallocatechin 3-gallate decreases localization ISO RGD:733705 6480464 epigallocatechin gallate results in decreased localization of CTNNB1 protein CTD PMID:16968065 (-)-epigallocatechin 3-gallate decreases phosphorylation ISO RGD:733705 6480464 epigallocatechin gallate results in decreased phosphorylation of CTNNB1 protein CTD PMID:16968065 (R)-adrenaline multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein]; more ... CTD PMID:26964897 (R)-adrenaline increases phosphorylation EXP 6480464 Epinephrine results in increased phosphorylation of CTNNB1 protein CTD PMID:26964897 (RS)-amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CTNNB1 protein CTD PMID:16144542 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions ISO RGD:733705 6480464 acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein]; more ... CTD PMID:20457140 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE increases cleavage ISO RGD:733705 6480464 Topotecan results in increased cleavage of CTNNB1 protein CTD PMID:20457140 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases expression ISO RGD:733705 6480464 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA CTD PMID:16580782 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases activity ISO RGD:733705 6480464 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased activity of CTNNB1 protein CTD PMID:19238344 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:733705 6480464 CDH2 protein affects the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:16580782 PMID:19238344 1,2-dimethylhydrazine increases expression EXP 6480464 1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein CTD PMID:29031619 1,2-dimethylhydrazine multiple interactions EXP 6480464 [chlorophyllin affects the reaction [1,2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene]] inhibits the reaction [GSK3B protein results in increased phosphorylation of and results in increased ubiquitination of CTNNB1 protein]; more ... CTD PMID:12628520 PMID:29031619 1,2-dimethylhydrazine increases mutagenesis EXP 6480464 1,2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene CTD PMID:12628520 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of CTNNB1 mRNA CTD PMID:24140754 17alpha-ethynylestradiol multiple interactions ISO RGD:1550466 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:733705 6480464 Estradiol inhibits the reaction [ESR1 protein promotes the reaction [BTRC protein binds to CTNNB1 protein]]; more ... CTD PMID:16053526 more ... 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:17170212 PMID:27174447 17beta-estradiol affects localization EXP 6480464 Estradiol affects the localization of CTNNB1 protein CTD PMID:17170212 17beta-estradiol increases expression ISO RGD:1550466 6480464 Estradiol results in increased expression of CTNNB1 mRNA CTD PMID:14648872 17beta-estradiol multiple interactions ISO RGD:1550466 6480464 [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein; more ... CTD PMID:11786374 PMID:23684557 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:733705 6480464 Metribolone promotes the reaction [NDRG1 protein binds to CTNNB1 protein] CTD PMID:17220478 2,2',4,4',5,5'-hexachlorobiphenyl increases degradation EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in increased degradation of CTNNB1 protein CTD PMID:19464575 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased phosphorylation of and results in decreased activity of CTNNB1 protein; more ... CTD PMID:19464575 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2,3,4,7,8-pentachlorodibenzofuran results in decreased expression of CTNNB1 mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin affects the expression of CTNNB1 mRNA CTD PMID:21570461 PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein CTD PMID:24231000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733705 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein CTD PMID:22902829 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733705 6480464 Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein CTD PMID:22134133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733705 6480464 Lithium Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein] CTD PMID:22134133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of CTNNB1 protein; more ... CTD PMID:21602191 PMID:24231000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 mRNA CTD PMID:17586704 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550466 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases activity ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin results in decreased activity of CTNNB1 protein CTD PMID:24928892 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CTNNB1 mRNA CTD PMID:21724226 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:1550466 6480464 [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein; more ... CTD PMID:16272459 2,6-dinitrotoluene affects expression EXP 6480464 2,6-dinitrotoluene affects the expression of CTNNB1 mRNA CTD PMID:21346803 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID multiple interactions ISO RGD:1550466 6480464 [Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased localization of and results in decreased activity of CTNNB1 protein CTD PMID:19015640 2-methoxy-17beta-estradiol decreases expression ISO RGD:733705 6480464 2-methoxyestradiol results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:18485479 2-methoxy-17beta-estradiol multiple interactions ISO RGD:733705 6480464 2-methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib] CTD PMID:18485479 2-nitrotoluene increases mutagenesis ISO RGD:1550466 6480464 2-nitrotoluene results in increased mutagenesis of CTNNB1 gene CTD PMID:13678655 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of CTNNB1 protein CTD PMID:12065681 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550466 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CTNNB1 mRNA CTD PMID:20188158 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide multiple interactions EXP 6480464 DRD2 protein affects the reaction [Raclopride results in increased expression of CTNNB1 protein] CTD PMID:16144542 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide increases expression EXP 6480464 Raclopride results in increased expression of CTNNB1 protein CTD PMID:16144542 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases expression ISO RGD:1550466 6480464 3,5-diethoxycarbonyl-1,4-dihydrocollidine results in decreased expression of CTNNB1 protein CTD PMID:23620592 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:1550466 6480464 CTNNB1 mutant form inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine affects the localization of FOXO3 protein]; more ... CTD PMID:23620592 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to 3,5-diethoxycarbonyl-1,4-dihydrocollidine CTD PMID:23620592 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:733705 6480464 [MK-886 binds to and results in decreased activity of PPARA protein] inhibits the reaction [perfluorooctanoic acid results in decreased expression of CTNNB1 protein] CTD PMID:23978332 3-aminobenzamide decreases expression ISO RGD:733705 6480464 3-aminobenzamide results in decreased expression of CTNNB1 mRNA CTD PMID:15670817 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1550466 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein; more ... CTD PMID:28285642 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases mutagenesis EXP 6480464 2-amino-3-methylimidazo(4,5-f)quinoline results in increased mutagenesis of CTNNB1 gene CTD PMID:12628520 PMID:9515794 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions EXP 6480464 [chlorophyllin affects the reaction [2-amino-3-methylimidazo(4,5-f)quinoline results in increased mutagenesis of CTNNB1 gene]] inhibits the reaction [GSK3B protein results in increased phosphorylation of and results in increased ubiquitination of CTNNB1 protein]; more ... CTD PMID:12628520 3-methylcholanthrene multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; more ... CTD PMID:21498875 PMID:25174530 3-methylcholanthrene affects response to substance ISO RGD:1550466 6480464 CTNNB1 protein affects the susceptibility to Methylcholanthrene CTD PMID:21498875 3-methylcholanthrene increases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in increased susceptibility to Methylcholanthrene CTD PMID:25174530 4,4'-diaminodiphenylmethane increases expression ISO RGD:1550466 6480464 4,4'-diaminodiphenylmethane results in increased expression of CTNNB1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:733705 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein; more ... CTD PMID:28321046 4-hydroxynon-2-enal decreases expression ISO RGD:733705 6480464 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:12419474 PMID:24825450 4-methylthio-2-oxobutanoic acid decreases expression ISO RGD:733705 6480464 2-keto-4-methylthiobutyric acid results in decreased expression of CTNNB1 protein CTD PMID:28414304 4-methylthio-2-oxobutanoic acid decreases expression ISO RGD:1550466 6480464 2-keto-4-methylthiobutyric acid results in decreased expression of CTNNB1 protein CTD PMID:28414304 5-aza-2'-deoxycytidine decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to decitabine CTD PMID:19234609 5-aza-2'-deoxycytidine decreases localization ISO RGD:733705 6480464 decitabine results in decreased localization of CTNNB1 protein CTD PMID:21515334 5-aza-2'-deoxycytidine decreases expression ISO RGD:1550466 6480464 decitabine results in decreased expression of CTNNB1 mRNA CTD PMID:19222872 5-aza-2'-deoxycytidine increases expression ISO RGD:733705 6480464 decitabine results in increased expression of CTNNB1 protein CTD PMID:19234609 5-aza-2'-deoxycytidine affects localization ISO RGD:733705 6480464 decitabine affects the localization of CTNNB1 protein CTD PMID:19387464 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide decreases expression ISO RGD:733705 6480464 Niclosamide results in decreased expression of CTNNB1 protein CTD PMID:21531761 more ... 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein]; more ... CTD PMID:26964897 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide decreases activity ISO RGD:733705 6480464 Niclosamide results in decreased activity of CTNNB1 protein CTD PMID:25174399 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide multiple interactions ISO RGD:733705 6480464 Niclosamide inhibits the reaction [CTNNB1 protein binds to CTNNBIP1 protein]; more ... CTD PMID:19772353 PMID:24534281 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide increases expression ISO RGD:733705 6480464 Niclosamide results in increased expression of CTNNB1 mRNA CTD PMID:22576131 5-formyltetrahydrofolic acid multiple interactions EXP 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of CTNNB1 protein CTD PMID:25187349 6-bromoindirubin-3'-oxime multiple interactions ISO RGD:733705 6480464 [6-bromoindirubin-3'-oxime co-treated with DHFR mRNA] affects the expression of CTNNB1 protein; more ... CTD PMID:19727391 6-bromoindirubin-3'-oxime increases expression ISO RGD:733705 6480464 6-bromoindirubin-3'-oxime results in increased expression of CTNNB1 protein CTD PMID:18624906 PMID:26259606 6-bromoindirubin-3'-oxime decreases phosphorylation ISO RGD:733705 6480464 6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein CTD PMID:19727391 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CTNNB1 mRNA CTD PMID:24780913 [6]-Shogaol decreases expression ISO RGD:733705 6480464 shogaol results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:27645308 acetylsalicylic acid decreases localization ISO RGD:733705 6480464 Aspirin results in decreased localization of CTNNB1 protein CTD PMID:16878161 PMID:17357503 acetylsalicylic acid multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Aspirin results in increased ubiquitination of CTNNB1 protein]; more ... CTD PMID:12813129 PMID:16878161 acetylsalicylic acid increases ubiquitination ISO RGD:733705 6480464 Aspirin results in increased ubiquitination of CTNNB1 protein CTD PMID:16878161 acetylsalicylic acid increases phosphorylation ISO RGD:733705 6480464 Aspirin results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 PMID:16878161 acrolein increases expression ISO RGD:733705 6480464 Acrolein results in increased expression of CTNNB1 protein CTD PMID:20525806 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CTNNB1 mRNA CTD PMID:28959563 Aeroplysinin 1 decreases expression ISO RGD:733705 6480464 aeroplysinin I results in decreased expression of CTNNB1 protein CTD PMID:27120392 AH23848 multiple interactions ISO RGD:733705 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [AXIN1 protein binds to CTNNB1 protein]; more ... CTD PMID:19407222 AICA ribonucleotide increases expression ISO RGD:1550466 6480464 AICA ribonucleotide results in increased expression of CTNNB1 mRNA; more ... CTD PMID:21454484 AICA ribonucleotide multiple interactions ISO RGD:1550466 6480464 [AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 mRNA; more ... CTD PMID:21454484 aldehydo-D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 aldehydo-D-glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:29163160 aldehydo-D-glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA; more ... CTD PMID:29163160 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:18004065 PMID:21818840 all-trans-retinoic acid multiple interactions ISO RGD:1550466 6480464 [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein; more ... CTD PMID:17170073 all-trans-retinoic acid decreases expression ISO RGD:733705 6480464 Tretinoin results in decreased expression of CTNNB1 mRNA CTD PMID:21924320 all-trans-retinoic acid decreases expression ISO RGD:1550466 6480464 Tretinoin results in decreased expression of CTNNB1 protein CTD PMID:17064353 all-trans-retinoic acid increases expression ISO RGD:1550466 6480464 Tretinoin results in increased expression of CTNNB1 mRNA CTD PMID:16236135 all-trans-retinoic acid increases expression ISO RGD:733705 6480464 Tretinoin results in increased expression of CTNNB1 protein CTD PMID:17219422 all-trans-retinol multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein]; more ... CTD PMID:17219422 all-trans-retinol decreases expression ISO RGD:733705 6480464 Vitamin A results in decreased expression of CTNNB1 protein CTD PMID:17219422 aluminium trichloride decreases expression EXP 6480464 aluminum chloride results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:26474975 ammonia affects metabolic processing ISO RGD:1550466 6480464 CTNNB1 protein affects the metabolism of Ammonia CTD PMID:16557553 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CTNNB1 mRNA CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of CTNNB1 protein CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CTNNB1 protein CTD PMID:16144542 arecoline multiple interactions ISO RGD:1550466 6480464 [Arecoline co-treated with 4-nitroquinolone-1-oxide] results in increased expression of CTNNB1 protein CTD PMID:26464283 Aroclor 1254 decreases expression ISO RGD:1550466 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CTNNB1 mRNA CTD PMID:23650126 arsane multiple interactions ISO RGD:733705 6480464 Arsenic results in increased expression of and results in increased activity of CTNNB1 protein; more ... CTD PMID:22552367 arsane increases expression ISO RGD:1550466 6480464 Arsenic results in increased expression of CTNNB1 protein CTD PMID:22552367 arsenic atom multiple interactions ISO RGD:733705 6480464 Arsenic results in increased expression of and results in increased activity of CTNNB1 protein; more ... CTD PMID:22552367 arsenic atom increases expression ISO RGD:1550466 6480464 Arsenic results in increased expression of CTNNB1 protein CTD PMID:22552367 arsenic trichloride increases expression ISO RGD:733705 6480464 arsenic trichloride results in increased expression of CTNNB1 protein CTD PMID:21854796 arsenic trichloride multiple interactions ISO RGD:733705 6480464 CAT protein inhibits the reaction [arsenic trichloride results in increased activity of CTNNB1 protein]; more ... CTD PMID:21854796 arsenic trichloride increases activity ISO RGD:733705 6480464 arsenic trichloride results in increased activity of CTNNB1 protein CTD PMID:21854796 arsenite(3-) affects localization ISO RGD:733705 6480464 arsenite affects the localization of CTNNB1 protein CTD PMID:17400267 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CTNNB1 protein CTD PMID:21344382 arsenite(3-) multiple interactions ISO RGD:733705 6480464 tyrphostin AG 1478 inhibits the reaction [arsenite affects the localization of CTNNB1 protein] CTD PMID:17400267 arsenite(3-) decreases phosphorylation ISO RGD:733705 6480464 arsenite results in decreased phosphorylation of CTNNB1 protein CTD PMID:17400267 arsenous acid increases expression ISO RGD:733705 6480464 arsenic trioxide results in increased expression of CTNNB1 mRNA CTD PMID:20458559 arsenous acid decreases expression ISO RGD:733705 6480464 arsenic trioxide results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:17512576 more ... arsenous acid increases cleavage ISO RGD:733705 6480464 arsenic trioxide results in increased cleavage of CTNNB1 protein CTD PMID:12181429 arsenous acid multiple interactions ISO RGD:733705 6480464 arsenic trioxide inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib] CTD PMID:18485479 artesunate multiple interactions EXP 6480464 artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein] CTD PMID:29031619 atropine multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form]; more ... CTD PMID:17390078 auraptene decreases expression EXP 6480464 aurapten results in decreased expression of CTNNB1 protein mutant form CTD PMID:16012713 benzo[a]pyrene increases expression ISO RGD:1550466 6480464 Benzo(a)pyrene results in increased expression of CTNNB1 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:733705 6480464 Benzo(a)pyrene metabolite results in increased expression of CTNNB1 mRNA; more ... CTD PMID:21714911 PMID:26314263 berberine increases expression ISO RGD:733705 6480464 Berberine results in increased expression of CTNNB1 protein CTD PMID:26478571 berberine multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of BGLAP protein]; more ... CTD PMID:26478571 beta-naphthoflavone multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; more ... CTD PMID:25174530 bis(2-ethylhexyl) phthalate affects localization ISO RGD:1550466 6480464 Diethylhexyl Phthalate affects the localization of CTNNB1 protein CTD PMID:20307648 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1550466 6480464 Diethylhexyl Phthalate results in increased expression of CTNNB1 mRNA CTD PMID:26219507 PMID:27495896 bisphenol A decreases expression ISO RGD:733705 6480464 bisphenol A results in decreased expression of CTNNB1 protein CTD PMID:26922907 bisphenol A decreases methylation ISO RGD:1550466 6480464 bisphenol A results in decreased methylation of CTNNB1 promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:733705 6480464 bisphenol A results in decreased expression of and affects the localization of CTNNB1 protein CTD PMID:24532171 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:19497385 more ... bisphenol A multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:25381574 more ... bisphenol A affects localization EXP 6480464 bisphenol A affects the localization of CTNNB1 protein CTD PMID:25381574 bisphenol A affects localization ISO RGD:1550466 6480464 bisphenol A affects the localization of CTNNB1 protein CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1550466 6480464 bisphenol A results in decreased expression of CTNNB1 mRNA CTD PMID:23900028 PMID:26063408 bisphenol F multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 boric acid multiple interactions ISO RGD:1550466 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein]; more ... CTD PMID:28285642 bortezomib multiple interactions ISO RGD:733705 6480464 2-methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib]; more ... CTD PMID:18485479 PMID:19100720 bortezomib decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to Bortezomib CTD PMID:18485479 bortezomib increases expression ISO RGD:733705 6480464 Bortezomib results in increased expression of CTNNB1 protein CTD PMID:18485479 PMID:19100720 bosutinib affects localization ISO RGD:733705 6480464 bosutinib affects the localization of CTNNB1 protein CTD PMID:16489032 bosutinib decreases phosphorylation ISO RGD:733705 6480464 bosutinib results in decreased phosphorylation of CTNNB1 protein CTD PMID:16489032 bosutinib multiple interactions ISO RGD:733705 6480464 bosutinib inhibits the reaction [CTNNB1 protein binds to TCF4 protein]; more ... CTD PMID:16489032 brazilein decreases expression ISO RGD:733705 6480464 brazilein results in decreased expression of CTNNB1 protein CTD PMID:23948132 bromocriptine multiple interactions ISO RGD:1550466 6480464 [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein CTD PMID:11786374 bucladesine increases phosphorylation EXP 6480464 Bucladesine results in increased phosphorylation of CTNNB1 protein CTD PMID:26964897 butylated hydroxyanisole multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A1 mRNA]; more ... CTD PMID:25174530 Butylbenzyl phthalate multiple interactions ISO RGD:733705 6480464 HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein]; more ... CTD PMID:22552774 Butylbenzyl phthalate increases acetylation ISO RGD:1550466 6480464 butylbenzyl phthalate results in increased acetylation of CTNNB1 protein CTD PMID:27923775 Butylbenzyl phthalate affects localization ISO RGD:733705 6480464 butylbenzyl phthalate affects the localization of CTNNB1 protein CTD PMID:22552774 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CTNNB1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of and results in increased activity of CTNNB1 protein]; more ... CTD PMID:22884995 PMID:24798214 cadmium atom increases activity ISO RGD:733705 6480464 Cadmium results in increased activity of CTNNB1 protein CTD PMID:22884995 cadmium atom affects localization ISO RGD:733705 6480464 Cadmium affects the localization of CTNNB1 protein CTD PMID:24798214 cadmium atom affects localization EXP 6480464 Cadmium affects the localization of CTNNB1 protein CTD PMID:23080431 cadmium dichloride affects localization EXP 6480464 Cadmium Chloride affects the localization of CTNNB1 protein CTD PMID:20459685 cadmium dichloride increases expression ISO RGD:733705 6480464 Cadmium Chloride results in increased expression of CTNNB1 mRNA; more ... CTD PMID:26472689 PMID:28527916 cadmium dichloride affects localization ISO RGD:733705 6480464 Cadmium Chloride affects the localization of CTNNB1 protein CTD PMID:24532171 cadmium dichloride multiple interactions ISO RGD:1550466 6480464 Cadmium Chloride results in increased phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:19818801 cadmium dichloride decreases activity ISO RGD:1550466 6480464 Cadmium Chloride results in decreased activity of CTNNB1 protein CTD PMID:19818801 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CTNNB1 protein CTD PMID:15618353 cadmium dichloride affects expression ISO RGD:1550466 6480464 Cadmium Chloride affects the expression of CTNNB1 mRNA CTD PMID:18974090 cadmium dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [CTNNB1 protein binds to CDH1 protein binds to CTNNA1 protein]; more ... CTD PMID:15618353 more ... caffeine increases mutagenesis EXP 6480464 Caffeine results in increased mutagenesis of CTNNB1 gene CTD PMID:18283038 calciol multiple interactions ISO RGD:1550466 6480464 [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein; more ... CTD PMID:17170073 calciol increases expression ISO RGD:1550466 6480464 Cholecalciferol results in increased expression of CTNNB1 mRNA CTD PMID:17170073 calcitriol multiple interactions ISO RGD:733705 6480464 [Calcitriol binds to VDR protein] which results in decreased activity of CTNNB1 mRNA; more ... CTD PMID:16051482 PMID:20043299 calcitriol decreases activity ISO RGD:733705 6480464 Calcitriol results in decreased activity of CTNNB1 protein CTD PMID:16051482 calcium atom increases expression ISO RGD:733705 6480464 Calcium results in increased expression of CTNNB1 mRNA; more ... CTD PMID:24658506 calcium atom multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA]; more ... CTD PMID:24658506 calcium(0) multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA]; more ... CTD PMID:24658506 calcium(0) increases expression ISO RGD:733705 6480464 Calcium results in increased expression of CTNNB1 mRNA; more ... CTD PMID:24658506 calyculin a increases phosphorylation ISO RGD:733705 6480464 calyculin A results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 PMID:16878161 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CTNNB1 protein CTD PMID:22150557 capsaicin multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; more ... CTD PMID:22150557 carbamazepine affects expression ISO RGD:733705 6480464 Carbamazepine affects the expression of CTNNB1 mRNA CTD PMID:24752500 celecoxib affects localization ISO RGD:733705 6480464 Celecoxib affects the localization of CTNNB1 protein; more ... CTD PMID:19682443 CGS-21680 affects localization ISO RGD:733705 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine affects the localization of CTNNB1 protein modified form CTD PMID:27595240 CGS-21680 multiple interactions ISO RGD:733705 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of and affects the phosphorylation of CTNNB1 protein; more ... CTD PMID:27595240 CHIR 99021 increases expression ISO RGD:733705 6480464 Chir 99021 results in increased expression of CTNNB1 protein CTD PMID:26259606 chitosan multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein] CTD PMID:28732690 chlordecone decreases expression ISO RGD:733705 6480464 Chlordecone results in decreased expression of CTNNB1 protein CTD PMID:11695219 chlorohydrocarbon increases expression ISO RGD:733705 6480464 Hydrocarbons, Chlorinated analog results in increased expression of CTNNB1 protein CTD PMID:24355586 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CTNNB1 mRNA CTD PMID:20691718 chromium(6+) multiple interactions ISO RGD:733705 6480464 CAT protein inhibits the reaction [chromium hexavalent ion results in increased expression of and results in increased activity of CTNNB1 protein]; more ... CTD PMID:22552367 PMID:27323401 chromium(6+) increases activity ISO RGD:733705 6480464 chromium hexavalent ion results in increased activity of CTNNB1 protein CTD PMID:27323401 chromium(6+) decreases expression ISO RGD:733705 6480464 chromium hexavalent ion results in decreased expression of CTNNB1 protein CTD PMID:23518002 chromium(6+) increases expression ISO RGD:1550466 6480464 chromium hexavalent ion results in increased expression of CTNNB1 protein CTD PMID:22552367 chrysin multiple interactions ISO RGD:733705 6480464 chrysin inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein] CTD PMID:20457140 chrysin 5,7-dimethyl ether multiple interactions EXP 6480464 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine affects the localization of CTNNB1 protein modified form]; more ... CTD PMID:21554863 cisplatin decreases expression ISO RGD:1550466 6480464 Cisplatin results in decreased expression of CTNNB1 protein CTD PMID:23628706 cisplatin decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Cisplatin CTD PMID:24560772 cisplatin increases phosphorylation ISO RGD:1550466 6480464 Cisplatin results in increased phosphorylation of CTNNB1 protein CTD PMID:24560772 cisplatin increases expression ISO RGD:733705 6480464 Cisplatin results in increased expression of CTNNB1 protein CTD PMID:20074550 cisplatin decreases localization ISO RGD:1550466 6480464 Cisplatin results in decreased localization of CTNNB1 protein CTD PMID:21745194 cisplatin multiple interactions ISO RGD:1550466 6480464 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate inhibits the reaction [Cisplatin results in decreased localization of CTNNB1 protein]; more ... CTD PMID:21745194 PMID:24560772 cisplatin decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Cisplatin CTD PMID:22000491 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of CTNNB1 mRNA CTD PMID:17602206 clozapine increases expression EXP 6480464 Clozapine results in increased expression of CTNNB1 protein CTD PMID:16144542 clozapine multiple interactions EXP 6480464 DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein] CTD PMID:16144542 cobalt dichloride decreases expression ISO RGD:733705 6480464 cobaltous chloride results in decreased expression of CTNNB1 mRNA CTD PMID:19320972 cobalt dichloride increases expression ISO RGD:733705 6480464 cobaltous chloride results in increased expression of CTNNB1 mRNA CTD PMID:17553155 PMID:26314263 cocaine affects expression EXP 6480464 Cocaine affects the expression of CTNNB1 mRNA CTD PMID:20187946 cocaine multiple interactions EXP 6480464 Cocaine deficiency promotes the reaction [SMARCA4 protein binds to CTNNB1 promoter] CTD PMID:27422367 corosolic acid increases degradation ISO RGD:733705 6480464 corosolic acid results in increased degradation of CTNNB1 protein CTD PMID:24566423 corticosterone multiple interactions ISO RGD:1550466 6480464 [Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; more ... CTD PMID:21655274 cortisol increases localization ISO RGD:733705 6480464 Hydrocortisone results in increased localization of CTNNB1 protein CTD PMID:25763180 cortisol multiple interactions ISO RGD:733705 6480464 GGTI 298 inhibits the reaction [Hydrocortisone results in increased localization of CTNNB1 protein] CTD PMID:25763180 crocidolite asbestos affects expression ISO RGD:733705 6480464 Asbestos, Crocidolite affects the expression of CTNNB1 mRNA; more ... CTD PMID:17331233 PMID:21570478 crocidolite asbestos multiple interactions ISO RGD:733705 6480464 Asbestos, Crocidolite results in increased phosphorylation of and affects the localization of CTNNB1 protein; more ... CTD PMID:24160326 curcumin decreases expression ISO RGD:733705 6480464 Curcumin analog results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:17041101 more ... curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [bisphenol A results in decreased expression of CTNNB1 mRNA]; more ... CTD PMID:25963729 curcumin decreases phosphorylation EXP 6480464 Curcumin results in decreased phosphorylation of CTNNB1 protein CTD PMID:25963729 curcumin increases expression EXP 6480464 Curcumin results in increased expression of CTNNB1 mRNA CTD PMID:25963729 curcumin decreases expression ISO RGD:1550466 6480464 Curcumin results in decreased expression of CTNNB1 protein CTD PMID:10783313 curcumin multiple interactions ISO RGD:733705 6480464 Curcumin inhibits the reaction [CTNNB1 protein binds to TCF7L2 protein]; more ... CTD PMID:19294764 PMID:27645308 curcumin increases degradation ISO RGD:733705 6480464 Curcumin analog results in increased degradation of CTNNB1 protein; more ... CTD PMID:17041101 cycloheximide decreases expression ISO RGD:1550466 6480464 Cycloheximide results in decreased expression of CTNNB1 protein CTD PMID:27693619 cycloheximide multiple interactions ISO RGD:1550466 6480464 Phenobarbital affects the reaction [Cycloheximide results in decreased expression of CTNNB1 protein] CTD PMID:27693619 cyclosporin A decreases expression ISO RGD:1550466 6480464 Cyclosporine results in decreased expression of CTNNB1 protein CTD PMID:22416070 cyclosporin A decreases expression ISO RGD:733705 6480464 Cyclosporine results in decreased expression of CTNNB1 mRNA CTD PMID:20106945 PMID:25562108 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:18004065 PMID:21818840 D-glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:29163160 D-glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA; more ... CTD PMID:29163160 D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 DDE increases activity ISO RGD:733705 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of CTNNB1 protein CTD PMID:27589886 DDE affects activity ISO RGD:733705 6480464 Dichlorodiphenyl Dichloroethylene affects the activity of CTNNB1 protein CTD PMID:25386960 DDE multiple interactions ISO RGD:733705 6480464 CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein]; more ... CTD PMID:25386960 DDT multiple interactions ISO RGD:733705 6480464 Acetylcysteine inhibits the reaction [DDT results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; more ... CTD PMID:22902829 PMID:24968063 DDT affects localization ISO RGD:733705 6480464 DDT affects the localization of CTNNB1 protein CTD PMID:24968063 DDT increases expression ISO RGD:733705 6480464 DDT results in increased expression of CTNNB1 protein CTD PMID:22902829 Deguelin decreases expression ISO RGD:733705 6480464 deguelin results in decreased expression of CTNNB1 protein CTD PMID:21472727 Deguelin increases degradation ISO RGD:733705 6480464 deguelin results in increased degradation of CTNNB1 protein CTD PMID:21472727 Deguelin multiple interactions ISO RGD:733705 6480464 [deguelin results in increased degradation of CTNNB1 protein] which results in decreased expression of CCND1 protein; more ... CTD PMID:21472727 PMID:22986522 delta-tocotrienol decreases expression ISO RGD:733705 6480464 tocotrienol, delta results in decreased expression of CTNNB1 protein CTD PMID:21453743 desferrioxamine B multiple interactions ISO RGD:733705 6480464 Deferoxamine inhibits the reaction [ferumoxides results in increased activity of CTNNB1 protein] CTD PMID:20338187 dexamethasone decreases expression ISO RGD:1550466 6480464 Dexamethasone results in decreased expression of CTNNB1 protein CTD PMID:20578217 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [2-amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:20501703 dexamethasone affects localization EXP 6480464 Dexamethasone affects the localization of CTNNB1 protein CTD PMID:20501703 dexamethasone multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:1550466 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein; more ... CTD PMID:28285642 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:18467435 PMID:20501703 dextran sulfate increases expression ISO RGD:1550466 6480464 Dextran Sulfate results in increased expression of CTNNB1 protein CTD PMID:16049979 dextran sulfate multiple interactions ISO RGD:1550466 6480464 [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of CTNNB1 protein; more ... CTD PMID:15459021 PMID:27664423 diallyl disulfide increases expression ISO RGD:733705 6480464 diallyl disulfide results in increased expression of CTNNB1 mRNA; more ... CTD PMID:20600798 diallyl disulfide decreases phosphorylation ISO RGD:733705 6480464 diallyl disulfide results in decreased phosphorylation of CTNNB1 protein CTD PMID:23663050 diallyl trisulfide increases cleavage ISO RGD:733705 6480464 diallyl trisulfide results in increased cleavage of CTNNB1 protein CTD PMID:22578287 diallyl trisulfide decreases phosphorylation ISO RGD:733705 6480464 diallyl trisulfide results in decreased phosphorylation of CTNNB1 protein CTD PMID:23663050 diarsenic trioxide multiple interactions ISO RGD:733705 6480464 arsenic trioxide inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib] CTD PMID:18485479 diarsenic trioxide decreases expression ISO RGD:733705 6480464 arsenic trioxide results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:17512576 more ... diarsenic trioxide increases expression ISO RGD:733705 6480464 arsenic trioxide results in increased expression of CTNNB1 mRNA CTD PMID:20458559 diarsenic trioxide increases cleavage ISO RGD:733705 6480464 arsenic trioxide results in increased cleavage of CTNNB1 protein CTD PMID:12181429 diazoxide multiple interactions ISO RGD:733705 6480464 Diazoxide inhibits the reaction [CTNNB1 protein results in increased activity of CCND1 promoter] CTD PMID:19052819 diazoxide decreases expression ISO RGD:733705 6480464 Diazoxide results in decreased expression of CTNNB1 protein CTD PMID:19052819 dibutyl phthalate affects localization ISO RGD:733705 6480464 Dibutyl Phthalate affects the localization of CTNNB1 protein CTD PMID:22552774 dibutyl phthalate multiple interactions ISO RGD:733705 6480464 HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein]; more ... CTD PMID:22552774 dichloromethane increases mutagenesis ISO RGD:1550466 6480464 Methylene Chloride results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 diclofenac affects expression ISO RGD:733705 6480464 Diclofenac affects the expression of CTNNB1 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RGD:733705 6480464 dicrotophos results in decreased expression of CTNNB1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:1550466 6480464 Diethylstilbestrol results in increased expression of CTNNB1 mRNA CTD PMID:14648872 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CTNNB1 protein CTD PMID:26911934 dimethyl sulfoxide increases expression ISO RGD:733705 6480464 Dimethyl Sulfoxide results in increased expression of CTNNB1 protein CTD PMID:20091315 diosgenin decreases expression ISO RGD:1550466 6480464 Diosgenin results in decreased expression of CTNNB1 mRNA CTD PMID:26408789 dioxygen multiple interactions ISO RGD:1550466 6480464 [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein; more ... CTD PMID:16272459 dioxygen affects localization ISO RGD:733705 6480464 Oxygen deficiency affects the localization of CTNNB1 protein CTD PMID:25297617 dioxygen multiple interactions ISO RGD:733705 6480464 [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in decreased expression of CTNNB1]; more ... CTD PMID:22245592 PMID:25297617 dioxygen decreases acetylation ISO RGD:733705 6480464 Oxygen deficiency results in decreased acetylation of CTNNB1 protein CTD PMID:22245592 dioxygen decreases expression ISO RGD:733705 6480464 Oxygen deficiency results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 disodium cromoglycate multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein] CTD PMID:28732690 diuron increases expression EXP 6480464 Diuron results in increased expression of CTNNB1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:1550466 6480464 CTNNB1 gene mutant form results in decreased susceptibility to Doxorubicin CTD PMID:20237062 doxorubicin multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; more ... CTD PMID:19047049 doxorubicin decreases phosphorylation ISO RGD:733705 6480464 Doxorubicin results in decreased phosphorylation of CTNNB1 protein CTD PMID:23956100 doxorubicin increases expression ISO RGD:1550466 6480464 Doxorubicin results in increased expression of CTNNB1 protein CTD PMID:20237062 eckol decreases expression ISO RGD:733705 6480464 eckol results in decreased expression of CTNNB1 protein CTD PMID:21514314 endosulfan multiple interactions ISO RGD:733705 6480464 Endosulfan inhibits the reaction [CDH1 protein binds to CTNNB1 protein]; more ... CTD PMID:22677888 PMID:22902829 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of CTNNB1 protein CTD PMID:26911934 endosulfan decreases expression ISO RGD:733705 6480464 Endosulfan results in decreased expression of CTNNB1 protein CTD PMID:28108160 Estradiol dipropionate multiple interactions ISO RGD:1550466 6480464 [estradiol dipropionate co-treated with Butyrates] results in decreased expression of CTNNB1 protein; more ... CTD PMID:15930180 ethanol multiple interactions ISO RGD:733705 6480464 Ethanol results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:26014148 ethanol affects response to substance ISO RGD:733705 6480464 CTNNB1 gene mutant form affects the susceptibility to Ethanol CTD PMID:25822088 ethosuximide multiple interactions EXP 6480464 Ethosuximide inhibits the reaction [APP protein modified form results in decreased expression of CTNNB1 mRNA] CTD PMID:26420483 ethosuximide increases expression EXP 6480464 Ethosuximide results in increased expression of CTNNB1 mRNA CTD PMID:26420483 ethosuximide decreases phosphorylation EXP 6480464 Ethosuximide results in decreased phosphorylation of CTNNB1 protein CTD PMID:26420483 ethosuximide multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Ethosuximide results in decreased phosphorylation of CTNNB1 protein] CTD PMID:26420483 etoposide multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein]; more ... CTD PMID:19047049 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CTNNB1 mRNA CTD PMID:23238999 flavonoids multiple interactions EXP 6480464 DKK1 protein inhibits the reaction [Flavonoids results in increased expression of CTNNB1 mRNA] CTD PMID:23238999 fluoxetine multiple interactions EXP 6480464 [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:21619414 PMID:21627639 flutamide affects localization ISO RGD:733705 6480464 Flutamide analog affects the localization of CTNNB1 protein CTD PMID:21111724 folic acid affects expression ISO RGD:733705 6480464 Folic Acid affects the expression of CTNNB1 mRNA CTD PMID:16361273 folic acid multiple interactions ISO RGD:1550466 6480464 [Folic Acid co-treated with sodium arsenite] results in increased methylation of CTNNB1 mRNA CTD PMID:22959928 formaldehyde decreases expression ISO RGD:733705 6480464 Formaldehyde results in decreased expression of CTNNB1 mRNA CTD PMID:23649840 fumonisin B1 increases expression ISO RGD:1550466 6480464 fumonisin B1 results in increased expression of CTNNB1 mRNA CTD PMID:16221962 geldanamycin multiple interactions ISO RGD:733705 6480464 geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]; more ... CTD PMID:17024233 gemcitabine increases expression ISO RGD:733705 6480464 gemcitabine results in increased expression of CTNNB1 mRNA CTD PMID:25605917 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein CTD PMID:16443925 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CTNNB1 mRNA CTD PMID:22061828 gingerol affects localization ISO RGD:733705 6480464 gingerol affects the localization of CTNNB1 protein CTD PMID:18058799 gingerol increases expression ISO RGD:1550466 6480464 gingerol results in increased expression of CTNNB1 mRNA CTD PMID:26498061 gingerol multiple interactions ISO RGD:1550466 6480464 gingerol results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:26498061 gingerol multiple interactions ISO RGD:733705 6480464 gingerol promotes the reaction [IL1B protein results in increased expression of CTNNB1 protein] CTD PMID:27645308 glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:18004065 PMID:21818840 glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA; more ... CTD PMID:29163160 glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:29163160 glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of CTNNB1 protein CTD PMID:28780397 haloperidol multiple interactions EXP 6480464 DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein] CTD PMID:16144542 haloperidol decreases expression ISO RGD:1550466 6480464 Haloperidol results in decreased expression of CTNNB1 mRNA CTD PMID:18797397 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of CTNNB1 protein CTD PMID:16144542 heptachlor multiple interactions ISO RGD:733705 6480464 Heptachlor inhibits the reaction [CDH1 protein binds to CTNNB1 protein] CTD PMID:22902829 heptachlor increases expression ISO RGD:733705 6480464 Heptachlor results in increased expression of CTNNB1 protein CTD PMID:22902829 hexachlorophene multiple interactions ISO RGD:733705 6480464 Hexachlorophene inhibits the reaction [Lithium Chloride results in increased expression of CTNNB1 protein]; more ... CTD PMID:16735606 hexachlorophene increases degradation ISO RGD:733705 6480464 Hexachlorophene results in increased degradation of CTNNB1 protein CTD PMID:16735606 hyaluronic acid multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; more ... CTD PMID:19047049 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of CTNNB1 protein CTD PMID:16204253 hydrogen peroxide multiple interactions ISO RGD:733705 6480464 Hydrogen Peroxide inhibits the reaction [CDH5 protein binds to CTNNB1 protein]; more ... CTD PMID:24211779 PMID:26482937 hydrogen peroxide multiple interactions EXP 6480464 pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein]; more ... CTD PMID:16204253 hydrogen peroxide decreases expression ISO RGD:733705 6480464 Hydrogen Peroxide results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:12419474 PMID:26482937 hydroxyflutamide decreases phosphorylation ISO RGD:733705 6480464 hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein CTD PMID:28163245 hydroxyflutamide multiple interactions ISO RGD:733705 6480464 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein]; more ... CTD PMID:28163245 indometacin affects localization ISO RGD:733705 6480464 Indomethacin affects the localization of CTNNB1 protein CTD PMID:15963497 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CTNNB1 protein CTD PMID:16818512 indometacin multiple interactions EXP 6480464 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein]; more ... CTD PMID:16818512 indometacin increases phosphorylation ISO RGD:733705 6480464 Indomethacin results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 indometacin decreases expression ISO RGD:733705 6480464 Indomethacin results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:11756231 PMID:15188006 indometacin multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:11756231 more ... ketanserin multiple interactions EXP 6480464 [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA CTD PMID:21627639 lactacystin multiple interactions ISO RGD:733705 6480464 lactacystin inhibits the reaction [Indomethacin results in decreased expression of CTNNB1 protein]; more ... CTD PMID:11756231 PMID:26040106 lead diacetate increases phosphorylation EXP 6480464 lead acetate results in increased phosphorylation of CTNNB1 protein CTD PMID:24999626 lead diacetate multiple interactions ISO RGD:733705 6480464 WNT7A protein inhibits the reaction [lead acetate results in increased phosphorylation of CTNNB1 protein] CTD PMID:24999626 lead(0) decreases expression ISO RGD:1550466 6480464 Lead results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:23086611 PMID:26518054 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:23086611 lead(2+) decreases expression ISO RGD:1550466 6480464 Lead results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:23086611 PMID:26518054 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:23086611 leupeptin multiple interactions EXP 6480464 leupeptin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased degradation of CTNNB1 protein] CTD PMID:19464575 lipopolysaccharide increases expression ISO RGD:733705 6480464 Lipopolysaccharides results in increased expression of CTNNB1 protein CTD PMID:11739494 lithium atom increases expression ISO RGD:1550466 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:19621015 lithium atom increases expression EXP 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:12942141 PMID:18296634 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of CTNNB1 mRNA CTD PMID:12942141 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:16288908 PMID:19149911 lithium atom affects localization EXP 6480464 Lithium affects the localization of CTNNB1 protein CTD PMID:18296634 lithium chloride multiple interactions ISO RGD:733705 6480464 [Lithium Chloride co-treated with ESR1 protein] results in increased expression of CTNNB1 protein; more ... CTD PMID:12813129 more ... lithium chloride increases expression EXP 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA CTD PMID:27045591 lithium chloride affects localization ISO RGD:733705 6480464 Lithium Chloride affects the localization of CTNNB1 protein; more ... CTD PMID:22493441 more ... lithium chloride increases stability ISO RGD:1550466 6480464 Lithium Chloride results in increased stability of CTNNB1 protein CTD PMID:23326414 lithium chloride increases expression ISO RGD:1550466 6480464 Lithium Chloride results in increased expression of CTNNB1 protein CTD PMID:22935447 lithium chloride increases activity EXP 6480464 Lithium Chloride results in increased activity of CTNNB1 protein CTD PMID:20694829 lithium chloride increases expression ISO RGD:733705 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA; more ... CTD PMID:16053526 more ... lithium chloride multiple interactions EXP 6480464 [[Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein] which affects the expression of GJA1 protein; more ... CTD PMID:18972237 more ... lithium chloride increases localization ISO RGD:1550466 6480464 Lithium Chloride results in increased localization of CTNNB1 protein CTD PMID:19442631 lithium chloride increases activity ISO RGD:1550466 6480464 Lithium Chloride results in increased activity of CTNNB1 protein CTD PMID:19582394 PMID:20118494 lithium chloride multiple interactions ISO RGD:1550466 6480464 [[Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein] which results in increased expression of GIP mRNA; more ... CTD PMID:15364539 more ... lithium chloride decreases phosphorylation ISO RGD:733705 6480464 Lithium Chloride results in decreased phosphorylation of CTNNB1 protein CTD PMID:16076840 lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:16288908 PMID:19149911 lithium hydride affects localization EXP 6480464 Lithium affects the localization of CTNNB1 protein CTD PMID:18296634 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of CTNNB1 mRNA CTD PMID:12942141 lithium hydride increases expression ISO RGD:1550466 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:19621015 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:12942141 PMID:18296634 lithocholic acid multiple interactions ISO RGD:733705 6480464 [Lithocholic Acid binds to VDR protein] which results in decreased activity of CTNNB1 mRNA CTD PMID:20043299 losartan multiple interactions ISO RGD:1550466 6480464 Losartan inhibits the reaction [AGT protein affects the localization of CTNNB1 protein]; more ... CTD PMID:28578904 losartan multiple interactions ISO RGD:733705 6480464 Losartan inhibits the reaction [AGT protein affects the localization of CTNNB1 protein]; more ... CTD PMID:28578904 lovastatin decreases degradation EXP 6480464 Lovastatin results in decreased degradation of CTNNB1 protein CTD PMID:19741129 lovastatin multiple interactions ISO RGD:733705 6480464 Lovastatin affects the localization of and results in increased expression of CTNNB1 protein CTD PMID:17234346 lupeol decreases expression ISO RGD:1550466 6480464 lupeol results in decreased expression of CTNNB1 protein CTD PMID:20979057 lupeol multiple interactions ISO RGD:733705 6480464 lupeol results in decreased localization of and results in decreased activity of CTNNB1 protein CTD PMID:20732907 LY294002 multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased stability of CTNNB1 protein]; more ... CTD PMID:20542495 more ... LY294002 decreases expression ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CTNNB1 protein CTD PMID:23143138 LY294002 multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of and results in increased activity of CTNNB1 protein]; more ... CTD PMID:19814765 more ... manganese atom decreases expression ISO RGD:733705 6480464 Manganese results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(0) decreases expression ISO RGD:733705 6480464 Manganese results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO RGD:733705 6480464 manganese chloride results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of CTNNB1 protein CTD PMID:24464479 manganese(II) chloride multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [manganese chloride results in decreased expression of CTNNB1 protein] CTD PMID:24464479 mangiferin decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to mangiferin CTD PMID:23707762 MeIQ affects mutagenesis ISO RGD:1550466 6480464 2-amino-3,4-dimethylimidazo(4,5-f)quinoline affects the mutagenesis of CTNNB1 exon CTD PMID:12893427 melatonin multiple interactions ISO RGD:733705 6480464 Melatonin inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CTNNB1 promoter]] CTD PMID:26990689 methamphetamine multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA] CTD PMID:19149911 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of CTNNB1 mRNA CTD PMID:19149911 methotrexate multiple interactions ISO RGD:733705 6480464 Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein] CTD PMID:19727391 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CTNNB1 protein CTD PMID:25187349 methotrexate multiple interactions EXP 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of CTNNB1 protein CTD PMID:25187349 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein CTD PMID:16443925 methyl methanesulfonate decreases expression ISO RGD:733705 6480464 Methyl Methanesulfonate results in decreased expression of CTNNB1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:733705 6480464 methylmercuric chloride results in increased expression of CTNNB1 mRNA CTD PMID:23179753 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CTNNB1 protein CTD PMID:28526320 methylmercury(1+) increases expression ISO RGD:733705 6480464 methylmercury II results in increased expression of CTNNB1 mRNA CTD PMID:26314263 microcystin-LR increases ubiquitination ISO RGD:733705 6480464 cyanoginosin LR results in increased ubiquitination of CTNNB1 protein CTD PMID:20421190 mifepristone increases expression ISO RGD:733705 6480464 Mifepristone results in increased expression of CTNNB1 mRNA CTD PMID:17584828 ML-7 decreases expression ISO RGD:733705 6480464 ML 7 results in decreased expression of CTNNB1 protein CTD PMID:18710790 ML-7 affects localization ISO RGD:733705 6480464 ML 7 affects the localization of CTNNB1 protein CTD PMID:18710790 mono(2-ethylhexyl) phthalate increases expression ISO RGD:733705 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CTNNB1 mRNA CTD PMID:22321834 Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of CTNNB1 mRNA CTD PMID:20864626 monocrotaline multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of CTNNB1 protein] CTD PMID:21619414 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CTNNB1 protein CTD PMID:21619414 myricetin decreases expression ISO RGD:733705 6480464 myricetin results in decreased expression of CTNNB1 protein CTD PMID:22245592 myricetin multiple interactions ISO RGD:733705 6480464 [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein CTD PMID:22245592 N(6),N(6)-dimethyladenine multiple interactions EXP 6480464 N(6),N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of CTNNB1 protein] CTD PMID:15618353 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:733705 6480464 [IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein; more ... CTD PMID:16844947 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:733705 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein modified form]; more ... CTD PMID:22493441 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein]; more ... CTD PMID:26964897 N-acetyl-L-cysteine multiple interactions ISO RGD:1550466 6480464 Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein] CTD PMID:19436114 N-acetyl-L-cysteine multiple interactions ISO RGD:733705 6480464 Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein]; more ... CTD PMID:16282376 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Aspirin results in increased ubiquitination of CTNNB1 protein]; more ... CTD PMID:14555707 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of CTNNB1 protein CTD PMID:26990689 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1550466 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the phosphorylation of and affects the localization of CTNNB1 protein; more ... CTD PMID:27693619 N-methyl-N-nitrosourea increases expression ISO RGD:1550466 6480464 Methylnitrosourea results in increased expression of CTNNB1 protein CTD PMID:12096346 N-nitrosodiethylamine multiple interactions ISO RGD:1550466 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased mutagenesis of CTNNB1 gene; more ... CTD PMID:20583210 more ... N-nitrosodiethylamine increases expression ISO RGD:1550466 6480464 Diethylnitrosamine results in increased expression of CTNNB1 mRNA; more ... CTD PMID:20583210 PMID:27058323 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CTNNB1 mRNA CTD PMID:21554863 N-nitrosodiethylamine affects localization EXP 6480464 Diethylnitrosamine affects the localization of CTNNB1 protein modified form CTD PMID:21554863 N-nitrosodiethylamine multiple interactions EXP 6480464 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine affects the localization of CTNNB1 protein modified form]; more ... CTD PMID:21554863 N-nitrosodiethylamine increases mutagenesis EXP 6480464 Diethylnitrosamine results in increased mutagenesis of CTNNB1 CTD PMID:10463579 N-nitrosodiethylamine decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:20583210 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO RGD:733705 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin inhibits the reaction [CTNNB1 protein binds to TCF4 protein]]; more ... CTD PMID:17030184 naproxen multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; more ... CTD PMID:22150557 naringin increases expression ISO RGD:733705 6480464 naringin results in increased expression of CTNNB1 mRNA CTD PMID:24915843 naringin multiple interactions ISO RGD:733705 6480464 naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein] CTD PMID:26482937 Niclosamide decreases activity ISO RGD:733705 6480464 Niclosamide results in decreased activity of CTNNB1 protein CTD PMID:25174399 Niclosamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein]; more ... CTD PMID:26964897 Niclosamide decreases expression ISO RGD:733705 6480464 Niclosamide results in decreased expression of CTNNB1 protein CTD PMID:21531761 more ... Niclosamide increases expression ISO RGD:733705 6480464 Niclosamide results in increased expression of CTNNB1 mRNA CTD PMID:22576131 Niclosamide multiple interactions ISO RGD:733705 6480464 Niclosamide inhibits the reaction [CTNNB1 protein binds to CTNNBIP1 protein]; more ... CTD PMID:19772353 PMID:24534281 nimesulide affects localization ISO RGD:733705 6480464 nimesulide affects the localization of CTNNB1 protein CTD PMID:16331303 nimesulide decreases expression ISO RGD:1550466 6480464 nimesulide results in decreased expression of CTNNB1 CTD PMID:15892897 nitroglycerin multiple interactions ISO RGD:733705 6480464 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein]; more ... CTD PMID:17030184 nitroglycerin decreases localization ISO RGD:733705 6480464 Nitroglycerin results in decreased localization of CTNNB1 protein CTD PMID:17030184 O-methyleugenol increases mutagenesis ISO RGD:1550466 6480464 methyleugenol results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 ochratoxin A increases expression ISO RGD:733705 6480464 ochratoxin A metabolite results in increased expression of CTNNB1 mRNA; more ... CTD PMID:26314263 okadaic acid increases phosphorylation ISO RGD:733705 6480464 Okadaic Acid results in increased phosphorylation of CTNNB1 protein CTD PMID:16878161 olanzapine decreases expression ISO RGD:1550466 6480464 olanzapine results in decreased expression of CTNNB1 mRNA CTD PMID:18797397 oxazepam increases mutagenesis ISO RGD:1550466 6480464 Oxazepam results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 paclitaxel decreases phosphorylation ISO RGD:733705 6480464 Paclitaxel results in decreased phosphorylation of CTNNB1 protein CTD PMID:23956100 paclitaxel decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Paclitaxel CTD PMID:22000491 palbociclib multiple interactions ISO RGD:733705 6480464 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [palbociclib results in increased expression of CTNNB1 protein] CTD PMID:22869556 palbociclib increases expression ISO RGD:733705 6480464 palbociclib results in increased expression of CTNNB1 protein CTD PMID:22869556 paracetamol affects expression ISO RGD:1550466 6480464 Acetaminophen affects the expression of CTNNB1 mRNA CTD PMID:17562736 PMID:19679878 paracetamol decreases expression ISO RGD:733705 6480464 Acetaminophen results in decreased expression of CTNNB1 mRNA CTD PMID:27761495 paracetamol increases expression ISO RGD:733705 6480464 Acetaminophen results in increased expression of CTNNB1 mRNA CTD PMID:21420995 paracetamol increases response to substance ISO RGD:1550466 6480464 CTNNB1 mutant form results in increased susceptibility to Acetaminophen CTD PMID:19679878 paracetamol multiple interactions ISO RGD:1550466 6480464 Acetaminophen results in increased expression of and results in increased activity of CTNNB1 protein CTD PMID:19679878 paracetamol affects localization ISO RGD:1550466 6480464 Acetaminophen affects the localization of CTNNB1 protein CTD PMID:19679878 paraquat multiple interactions ISO RGD:1550466 6480464 CTNNB1 protein inhibits the reaction [Paraquat results in increased abundance of Reactive Oxygen Species] CTD PMID:23620592 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CTNNB1 mRNA CTD PMID:26887261 paraquat decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Paraquat CTD PMID:23620592 parathion multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form]; more ... CTD PMID:17390078 parathion increases expression ISO RGD:733705 6480464 Parathion results in increased expression of CTNNB1 protein CTD PMID:17390078 perfluorooctanoic acid decreases expression ISO RGD:733705 6480464 perfluorooctanoic acid results in decreased expression of CTNNB1 protein CTD PMID:23978332 perfluorooctanoic acid decreases expression ISO RGD:1550466 6480464 perfluorooctanoic acid results in decreased expression of CTNNB1 protein CTD PMID:25743374 perfluorooctanoic acid multiple interactions ISO RGD:733705 6480464 [MK-886 binds to and results in decreased activity of PPARA protein] inhibits the reaction [perfluorooctanoic acid results in decreased expression of CTNNB1 protein] CTD PMID:23978332 phenethyl caffeate decreases expression ISO RGD:1550466 6480464 caffeic acid phenethyl ester results in decreased expression of CTNNB1 protein CTD PMID:10783313 phenobarbital affects response to substance ISO RGD:1550466 6480464 CTNNB1 protein affects the susceptibility to Phenobarbital CTD PMID:21705713 phenobarbital increases mutagenesis ISO RGD:1550466 6480464 Phenobarbital results in increased mutagenesis of CTNNB1 gene; more ... CTD PMID:11753661 PMID:12384525 phenobarbital multiple interactions ISO RGD:1550466 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased mutagenesis of CTNNB1 gene; more ... CTD PMID:12384525 more ... phenylephrine multiple interactions EXP 6480464 Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter] CTD PMID:19799869 phenylmercury acetate increases expression ISO RGD:733705 6480464 Phenylmercuric Acetate results in increased expression of CTNNB1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA CTD PMID:27188386 PhIP multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dietary Fats] affects the localization of CTNNB1 protein; more ... CTD PMID:11756241 more ... PhIP multiple interactions ISO RGD:1550466 6480464 [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of CTNNB1 protein; more ... CTD PMID:15459021 PMID:27664423 PhIP increases mutagenesis EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of CTNNB1 gene CTD PMID:10965019 more ... PhIP increases expression ISO RGD:1550466 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CTNNB1 protein CTD PMID:21081470 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CTNNB1 mRNA; more ... CTD PMID:14507667 PMID:23466459 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733705 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [CDH5 protein binds to CTNNB1 protein] CTD PMID:24211779 pinosylvin multiple interactions ISO RGD:733705 6480464 [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA; more ... CTD PMID:23333577 pioglitazone multiple interactions ISO RGD:733705 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA CTD PMID:20847119 pirinixic acid multiple interactions EXP 6480464 pirinixic acid inhibits the reaction [APP protein results in decreased expression of CTNNB1 protein]; more ... CTD PMID:16204253 pirinixic acid decreases expression ISO RGD:1550466 6480464 pirinixic acid results in decreased expression of CTNNB1 mRNA CTD PMID:18445702 pravastatin affects localization EXP 6480464 Pravastatin affects the localization of CTNNB1 protein CTD PMID:17188708 pravastatin multiple interactions EXP 6480464 [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein CTD PMID:17188708 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CTNNB1 protein CTD PMID:17170212 progesterone decreases abundance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased abundance of Progesterone CTD PMID:20610534 progesterone increases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in increased susceptibility to Progesterone CTD PMID:22958837 prostaglandin E2 increases localization ISO RGD:733705 6480464 Dinoprostone results in increased localization of CTNNB1 protein CTD PMID:18395713 puromycin affects localization ISO RGD:1550466 6480464 Puromycin affects the localization of CTNNB1 protein CTD PMID:15673299 pyrithione multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein CTD PMID:17098228 quercetin decreases expression ISO RGD:733705 6480464 Quercetin results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:20596804 more ... quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:20501703 quercetin multiple interactions EXP 6480464 Quercetin promotes the reaction [Dexamethasone results in decreased expression of CTNNB1 mRNA]; more ... CTD PMID:20501703 quercetin multiple interactions ISO RGD:733705 6480464 [Quercetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein; more ... CTD PMID:15670774 more ... quercetin decreases activity ISO RGD:733705 6480464 Quercetin results in decreased activity of CTNNB1 protein CTD PMID:15670774 PMID:19440933 quercetin affects expression ISO RGD:733705 6480464 Quercetin affects the expression of CTNNB1 protein CTD PMID:15670774 quinacrine multiple interactions ISO RGD:733705 6480464 GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein] CTD PMID:28720477 quinacrine decreases expression ISO RGD:733705 6480464 Quinacrine results in decreased expression of CTNNB1 protein CTD PMID:28720477 reactive oxygen species multiple interactions ISO RGD:1550466 6480464 CTNNB1 protein inhibits the reaction [Paraquat results in increased abundance of Reactive Oxygen Species] CTD PMID:23620592 resveratrol affects localization EXP 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:17188708 resveratrol affects localization ISO RGD:733705 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:22314268 more ... resveratrol increases degradation ISO RGD:733705 6480464 resveratrol results in increased degradation of CTNNB1 protein CTD PMID:26040106 resveratrol decreases expression ISO RGD:733705 6480464 resveratrol results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:11895924 more ... resveratrol affects localization ISO RGD:1550466 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:19665018 resveratrol multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased stability of CTNNB1 protein]; more ... CTD PMID:20542495 more ... resveratrol increases activity ISO RGD:1550466 6480464 resveratrol results in increased activity of CTNNB1 protein CTD PMID:19665018 resveratrol increases stability ISO RGD:1550466 6480464 resveratrol results in increased stability of CTNNB1 protein CTD PMID:19665018 PMID:20542495 resveratrol multiple interactions ISO RGD:733705 6480464 [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein; more ... CTD PMID:19047049 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of CTNNB1 mRNA CTD PMID:23848300 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein CTD PMID:17188708 riboflavin increases expression ISO RGD:1550466 6480464 Riboflavin analog results in increased expression of CTNNB1 protein CTD PMID:20688149 risperidone multiple interactions EXP 6480464 DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein] CTD PMID:16144542 risperidone increases expression EXP 6480464 Risperidone results in increased expression of CTNNB1 protein CTD PMID:16144542 rosiglitazone increases expression ISO RGD:1550466 6480464 rosiglitazone results in increased expression of CTNNB1 protein CTD PMID:19621015 rosiglitazone multiple interactions ISO RGD:733705 6480464 [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:20847119 rotenone multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [Rotenone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein]; more ... CTD PMID:27045591 Salinomycin multiple interactions ISO RGD:733705 6480464 salinomycin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased activity of CTNNB1 mRNA] CTD PMID:26896736 SB 203580 multiple interactions ISO RGD:733705 6480464 SB 203580 inhibits the reaction [DEFA1 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein]; more ... CTD PMID:19814765 SB 415286 multiple interactions ISO RGD:1550466 6480464 [3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein CTD PMID:19159680 SB 431542 multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:733705 6480464 Asbestos, Serpentine results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:26685284 serpentine asbestos multiple interactions ISO RGD:733705 6480464 Asbestos, Serpentine results in increased phosphorylation of and affects the localization of CTNNB1 protein; more ... CTD PMID:24160326 PMID:26685284 simvastatin multiple interactions ISO RGD:1550466 6480464 CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of BGLAP protein]; more ... CTD PMID:22058016 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CTNNB1 protein CTD PMID:18004065 simvastatin increases expression ISO RGD:1550466 6480464 Simvastatin results in increased expression of CTNNB1 protein CTD PMID:22058016 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:14713550 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CTNNB1 mRNA CTD PMID:23137061 sodium arsenite affects localization ISO RGD:733705 6480464 sodium arsenite affects the localization of CTNNB1 protein CTD PMID:22859221 sodium arsenite increases expression ISO RGD:1550466 6480464 sodium arsenite results in increased expression of CTNNB1 mRNA CTD PMID:25825268 sodium arsenite decreases expression ISO RGD:1550466 6480464 sodium arsenite results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:23143138 PMID:27158593 sodium arsenite affects expression ISO RGD:1550466 6480464 sodium arsenite affects the expression of CTNNB1 mRNA CTD PMID:16507464 PMID:28206643 sodium arsenite multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [sodium arsenite results in decreased expression of CTNNB1 protein]; more ... CTD PMID:22959928 PMID:23143138 sodium arsenite increases expression ISO RGD:733705 6480464 sodium arsenite results in increased expression of CTNNB1 protein CTD PMID:16054901 more ... sodium arsenite decreases expression ISO RGD:733705 6480464 sodium arsenite results in decreased expression of CTNNB1 protein CTD PMID:23219847 PMID:25879800 sodium arsenite multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite affects the localization of CTNNB1 protein]; more ... CTD PMID:22859221 more ... sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of CTNNB1 mRNA CTD PMID:24300170 sodium fluoride decreases expression ISO RGD:1550466 6480464 Sodium Fluoride results in decreased expression of CTNNB1 protein CTD PMID:28918527 sodium fluoride multiple interactions EXP 6480464 Sodium Fluoride results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:24300170 sorafenib multiple interactions ISO RGD:733705 6480464 sorafenib promotes the reaction [destruxin B results in decreased expression of CTNNB1 protein] CTD PMID:24434019 Sporidesmin affects localization ISO RGD:733705 6480464 sporidesmin affects the localization of CTNNB1 protein CTD PMID:28193462 staurosporine increases phosphorylation EXP 6480464 Staurosporine results in increased phosphorylation of CTNNB1 protein CTD PMID:19741129 SU6656 affects localization ISO RGD:733705 6480464 SU 6656 affects the localization of CTNNB1 protein CTD PMID:23527294 sulfasalazine multiple interactions ISO RGD:1550466 6480464 [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA; more ... CTD PMID:19015640 sulindac multiple interactions ISO RGD:733705 6480464 CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein]; more ... CTD PMID:11751639 PMID:18291362 sulindac decreases expression ISO RGD:1550466 6480464 Sulindac results in decreased expression of CTNNB1 protein CTD PMID:10223192 sulindac multiple interactions ISO RGD:1550466 6480464 [Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein CTD PMID:12351151 sulindac decreases expression ISO RGD:733705 6480464 Sulindac results in decreased expression of CTNNB1 protein CTD PMID:18291362 sulindac sulfide multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of CTNNB1 protein]; more ... CTD PMID:14555707 more ... sulindac sulfide decreases expression ISO RGD:733705 6480464 sulindac sulfide results in decreased expression of CTNNB1 protein CTD PMID:14555707 sulindac sulfone increases expression ISO RGD:733705 6480464 sulindac sulfone results in increased expression of CTNNB1 protein CTD PMID:11602670 sulindac sulfone decreases expression ISO RGD:733705 6480464 sulindac sulfone results in decreased expression of CTNNB1 protein CTD PMID:10910034 more ... sulindac sulfone multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of CTNNB1 protein] CTD PMID:14555707 sumatriptan multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; more ... CTD PMID:22150557 sunitinib increases expression ISO RGD:733705 6480464 sunitinib results in increased expression of CTNNB1 mRNA CTD PMID:25605917 tamoxifen multiple interactions ISO RGD:733705 6480464 3,4',5-trimethoxystilbene promotes the reaction [Tamoxifen results in decreased expression of CTNNB1 protein]; more ... CTD PMID:22046442 PMID:23921149 tamoxifen decreases expression ISO RGD:733705 6480464 Tamoxifen results in decreased expression of CTNNB1 protein CTD PMID:23921149 tert-butyl hydroperoxide multiple interactions ISO RGD:733705 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:733705 6480464 tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA CTD PMID:20847119 testosterone increases expression ISO RGD:733705 6480464 Testosterone results in increased expression of CTNNB1 protein CTD PMID:21468052 testosterone multiple interactions ISO RGD:733705 6480464 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Testosterone results in decreased phosphorylation of CTNNB1 protein]; more ... CTD PMID:28163245 testosterone decreases phosphorylation ISO RGD:733705 6480464 Testosterone results in decreased phosphorylation of CTNNB1 protein CTD PMID:28163245 testosterone increases expression ISO RGD:1550466 6480464 Testosterone results in increased expression of CTNNB1 protein CTD PMID:21468052 tetrachloromethane multiple interactions ISO RGD:1550466 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]]; more ... CTD PMID:27477297 tetrachloromethane increases expression ISO RGD:1550466 6480464 Carbon Tetrachloride results in increased expression of CTNNB1 protein CTD PMID:27477297 tetramethylpyrazine decreases expression ISO RGD:733705 6480464 tetramethylpyrazine results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:27477297 tetramethylpyrazine multiple interactions ISO RGD:733705 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of CTNNB1 mRNA]; more ... CTD PMID:24961358 PMID:27477297 tetramethylpyrazine multiple interactions ISO RGD:1550466 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]]; more ... CTD PMID:27477297 theaflavin multiple interactions ISO RGD:1550466 6480464 theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA]; more ... CTD PMID:27058323 titanium dioxide affects expression ISO RGD:1550466 6480464 titanium dioxide affects the expression of CTNNB1 mRNA CTD PMID:17656681 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:1550466 6480464 Toluene 2,4-Diisocyanate results in increased phosphorylation of CTNNB1 protein CTD PMID:26089345 toluene 2,4-diisocyanate multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Toluene 2,4-Diisocyanate results in decreased expression of and affects the localization of CTNNB1 protein]; more ... CTD PMID:26089345 topotecan multiple interactions ISO RGD:733705 6480464 acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein]; more ... CTD PMID:20457140 topotecan increases cleavage ISO RGD:733705 6480464 Topotecan results in increased cleavage of CTNNB1 protein CTD PMID:20457140 trans-pinosylvin multiple interactions ISO RGD:733705 6480464 [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA; more ... CTD PMID:23333577 trans-resveratrol affects localization EXP 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:17188708 trans-resveratrol increases degradation ISO RGD:733705 6480464 resveratrol results in increased degradation of CTNNB1 protein CTD PMID:26040106 trans-resveratrol affects localization ISO RGD:733705 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:22314268 more ... trans-resveratrol decreases expression ISO RGD:733705 6480464 resveratrol results in decreased expression of CTNNB1 mRNA; more ... CTD PMID:11895924 more ... trans-resveratrol affects localization ISO RGD:1550466 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:19665018 trans-resveratrol multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased stability of CTNNB1 protein]; more ... CTD PMID:20542495 more ... trans-resveratrol increases activity ISO RGD:1550466 6480464 resveratrol results in increased activity of CTNNB1 protein CTD PMID:19665018 trans-resveratrol increases stability ISO RGD:1550466 6480464 resveratrol results in increased stability of CTNNB1 protein CTD PMID:19665018 PMID:20542495 trans-resveratrol multiple interactions ISO RGD:733705 6480464 [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein; more ... CTD PMID:19047049 more ... trans-resveratrol increases expression EXP 6480464 resveratrol results in increased expression of CTNNB1 mRNA CTD PMID:23848300 trans-resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein CTD PMID:17188708 tremolite asbestos multiple interactions ISO RGD:733705 6480464 tremolite results in decreased expression of and affects the localization of CTNNB1 protein CTD PMID:22578742 tributylstannane increases expression ISO RGD:733705 6480464 tributyltin results in increased expression of CTNNB1 mRNA CTD PMID:26314263 Tributyltin oxide increases expression ISO RGD:733705 6480464 bis(tri-n-butyltin)oxide results in increased expression of CTNNB1 mRNA CTD PMID:26314263 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CTNNB1 mRNA CTD PMID:14565619 trichostatin A multiple interactions ISO RGD:733705 6480464 [3-deazaneplanocin co-treated with trichostatin A] affects the expression of CTNNB1 protein; more ... CTD PMID:18538736 more ... trichostatin A increases expression ISO RGD:733705 6480464 trichostatin A results in increased expression of CTNNB1 mRNA CTD PMID:24935251 PMID:26272509 trichostatin A multiple interactions ISO RGD:1550466 6480464 [estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein CTD PMID:15930180 troglitazone multiple interactions ISO RGD:733705 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; more ... CTD PMID:20847119 troglitazone decreases expression ISO RGD:1550466 6480464 troglitazone results in decreased expression of CTNNB1 CTD PMID:15892897 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form]; more ... CTD PMID:17390078 tyrphostin AG 1478 multiple interactions ISO RGD:733705 6480464 tyrphostin AG 1478 inhibits the reaction [arsenite affects the localization of CTNNB1 protein] CTD PMID:17400267 uranium atom decreases expression EXP 6480464 Uranium analog results in decreased expression of CTNNB1 mRNA CTD PMID:27544493 ursolic acid multiple interactions ISO RGD:733705 6480464 ursolic acid results in increased phosphorylation of and results in increased degradation of CTNNB1 protein CTD PMID:24566423 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CTNNB1 protein CTD PMID:12942141 PMID:20734317 valproic acid multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733705 6480464 Valproic Acid results in increased expression of CTNNB1 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO RGD:733705 6480464 Valproic Acid affects the expression of CTNNB1 mRNA CTD PMID:23179753 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of CTNNB1 protein CTD PMID:18511088 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CTNNB1 mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:733705 6480464 Vincristine results in increased expression of CTNNB1 mRNA CTD PMID:23649840 vincristine decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Vincristine CTD PMID:22000491 vinyl carbamate increases mutagenesis ISO RGD:1550466 6480464 vinyl carbamate results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 Vomitoxin affects phosphorylation ISO RGD:1550466 6480464 deoxynivalenol affects the phosphorylation of CTNNB1 protein CTD PMID:23811945 vorinostat multiple interactions ISO RGD:733705 6480464 vorinostat results in increased expression of and results in increased activity of CTNNB1 protein CTD PMID:17417771 warfarin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Warfarin results in increased expression of and affects the localization of CTNNB1 protein]; more ... CTD PMID:23117658 warfarin affects response to substance EXP 6480464 CTNNB1 protein affects the susceptibility to Warfarin CTD PMID:23223575 warfarin multiple interactions ISO RGD:733705 6480464 Warfarin results in decreased expression of and affects the localization of CTNNB1 protein CTD PMID:26206560 wogonin multiple interactions ISO RGD:733705 6480464 Lithium Chloride inhibits the reaction [wogonin results in decreased expression of CTNNB1 protein] CTD PMID:23872260 wogonin multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [wogonin results in decreased expression of CTNNB1 protein] CTD PMID:23872260 wogonin increases expression ISO RGD:733705 6480464 wogonin results in increased expression of CTNNB1 protein modified form CTD PMID:23872260 wogonin decreases expression ISO RGD:733705 6480464 wogonin results in decreased expression of CTNNB1 protein CTD PMID:23872260 wogonin decreases expression EXP 6480464 wogonin results in decreased expression of CTNNB1 protein CTD PMID:23872260 wogonin increases expression EXP 6480464 wogonin results in increased expression of CTNNB1 protein modified form CTD PMID:23872260 wortmannin decreases expression ISO RGD:733705 6480464 wortmannin results in decreased expression of CTNNB1 protein CTD PMID:11739494 wortmannin multiple interactions ISO RGD:733705 6480464 wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTNNB1 protein]; more ... CTD PMID:28163245 PMID:28321046 wortmannin increases phosphorylation ISO RGD:733705 6480464 wortmannin results in increased phosphorylation of CTNNB1 protein CTD PMID:28163245 XAV939 multiple interactions ISO RGD:733705 6480464 XAV939 inhibits the reaction [CTNNB1 protein binds to CTNNBIP1 protein]; more ... CTD PMID:24534281 XAV939 decreases expression EXP 6480464 XAV939 results in decreased expression of CTNNB1 protein CTD PMID:24231000 XAV939 multiple interactions EXP 6480464 XAV939 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein] CTD PMID:24231000 XAV939 decreases expression ISO RGD:733705 6480464 XAV939 results in decreased expression of CTNNB1 protein CTD PMID:25061499 zinc atom multiple interactions ISO RGD:733705 6480464 Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] CTD PMID:16844947 zinc atom multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein; more ... CTD PMID:17098228 PMID:21893222 zinc(0) multiple interactions ISO RGD:733705 6480464 Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] CTD PMID:16844947 zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein; more ... CTD PMID:17098228 PMID:21893222
Biological Process adherens junction assembly ISO RGD:733705 1624291 RGD PMID:20086044 PMID:20123964 adherens junction assembly IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 adherens junction assembly ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 adherens junction organization ISO RGD:1550466 1624291 RGD MGI:MGI:3829282 PMID:19129494 animal organ development ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3807613 PMID:18635608 anterior/posterior axis specification ISO RGD:1550466 1624291 MGI:MGI:2148590 RGD MGI:MGI:1353237 PMID:10662781 anterior/posterior axis specification IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 bicellular tight junction assembly ISO RGD:12299678 1624291 RGD PMID:8636221 bone resorption ISO RGD:1550466 1624291 MGI:MGI:1858008|MGI:MGI:2148567|MGI:MGI:3041864|MGI:MGI:98504 RGD MGI:MGI:3578468 PMID:15866165 bone resorption IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 branching involved in blood vessel morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1858008|MGI:MGI:2148567 RGD MGI:MGI:2675534 more ... branching involved in blood vessel morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 branching involved in ureteric bud morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3714576 PMID:17537789 branching involved in ureteric bud morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 canonical Wnt signaling pathway ISO RGD:733705 1624291 RGD PMID:10644691 more ... canonical Wnt signaling pathway ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 canonical Wnt signaling pathway ISO RGD:1550466 1624291 MGI:MGI:109330|MGI:MGI:1261834|MGI:MGI:2148567|MGI:MGI:2446084|MGI:MGI:3577106|MGI:MGI:98954|MGI:MGI:98957 RGD MGI:MGI:2386811 more ... canonical Wnt signaling pathway involved in negative regulation of apoptotic process ISO RGD:733705 1624291 RGD PMID:12154096 canonical Wnt signaling pathway involved in negative regulation of apoptotic process IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation ISO RGD:1550466 1624291 RGD MGI:MGI:2446944 PMID:12464179 canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition ISO RGD:733705 1624291 RGD PMID:17072303 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cell adhesion ISO RGD:733705 1624291 RGD PMID:19101069 cell adhesion ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cell adhesion NAS 10395276 PMID:12610652 ARUK-UCL cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2148569 RGD MGI:MGI:3051737 more ... cell fate determination ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2176173 RGD MGI:MGI:3529734 PMID:15708565 cell fate specification ISO RGD:1550466 1624291 MGI:MGI:2148591|MGI:MGI:2148594|MGI:MGI:2450929 RGD MGI:MGI:3578464 PMID:15866163 cell fate specification IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell maturation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3044412 RGD MGI:MGI:3511731 more ... cell maturation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell morphogenesis involved in differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3045749 RGD MGI:MGI:3603687 PMID:16102745 cell morphogenesis involved in differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell proliferation ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3051737 PMID:15131783 cell-cell adhesion IDA 1626295 RGD cell-cell adhesion IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell-cell adhesion ISS UniProtKB:Q9UI47 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cell-cell adhesion ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3045749 RGD MGI:MGI:3603687 PMID:16102745 cell-cell adhesion IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell-cell adhesion TAS 8554709 PMID:20299672 DFLAT cell-cell adhesion ISO RGD:733705 1624291 RGD PMID:18593713 cell-matrix adhesion ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3051737 PMID:15131783 cell-matrix adhesion IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular process ISO RGD:1550466 1624291 RGD MGI:MGI:2662628 PMID:12717450 cellular protein localization ISO RGD:1550466 1624291 RGD MGI:MGI:3689461 PMID:16621792 cellular response to fibroblast growth factor stimulus IEP 728475 RGD cellular response to growth factor stimulus ISO RGD:733705 1624291 RGD PMID:16858403 cellular response to growth factor stimulus IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to growth factor stimulus ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cellular response to indole-3-methanol ISO RGD:733705 1624291 RGD PMID:10868478 cellular response to indole-3-methanol IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to indole-3-methanol ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cellular response to insulin-like growth factor stimulus IMP 7242068 RGD cellular response to insulin-like growth factor stimulus IEP 7242068 RGD cellular response to lithium ion IEP 10395276 RGD cellular response to mechanical stimulus IDA 7242068 RGD central nervous system vasculogenesis ISO RGD:1550466 1624291 MGI:MGI:2148569 RGD MGI:MGI:3821408 PMID:19023080 central nervous system vasculogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 chemical synaptic transmission ISO RGD:1550466 1624291 MGI:MGI:2148594 RGD MGI:MGI:2680876 PMID:14622577 chemical synaptic transmission IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 chromatin-mediated maintenance of transcription ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 chromatin-mediated maintenance of transcription IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cranial ganglion development ISO RGD:1550466 1624291 RGD MGI:MGI:1931800 PMID:11262227 cranial ganglion development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cranial skeletal system development ISO RGD:1550466 1624291 RGD MGI:MGI:1931800 PMID:11262227 cranial skeletal system development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 dorsal root ganglion development ISO RGD:1550466 1624291 RGD MGI:MGI:1931800 PMID:11262227 dorsal root ganglion development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 dorsal/ventral axis specification ISO RGD:1550466 1624291 MGI:MGI:2148594|MGI:MGI:2158470 RGD MGI:MGI:2670493 PMID:12923052 dorsal/ventral axis specification IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 dorsal/ventral pattern formation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2176173 RGD MGI:MGI:3529734 PMID:15708565 ectoderm development ISO RGD:1550466 1624291 MGI:MGI:1857678 RGD MGI:MGI:77405 PMID:8582267 ectoderm development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic axis specification ISO RGD:1550466 1624291 RGD MGI:MGI:894149 PMID:9230313 embryonic axis specification IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic brain development ISO RGD:1550466 1624291 RGD MGI:MGI:1931800 PMID:11262227 embryonic brain development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic digit morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1338938|MGI:MGI:1858008|MGI:MGI:2148594|MGI:MGI:2158470 RGD MGI:MGI:2670493 more ... embryonic digit morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic foregut morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3820452 PMID:18692041 embryonic foregut morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic forelimb morphogenesis ISO RGD:1550466 1624291 RGD MGI:MGI:3055626 PMID:15371327 embryonic forelimb morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic heart tube development ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3773938 PMID:18231602 embryonic heart tube development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic hindlimb morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2148594|MGI:MGI:2158470 RGD MGI:MGI:2670493 more ... embryonic hindlimb morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic skeletal limb joint morphogenesis ISO RGD:1550466 1624291 UniProtKB:Q91ZD1 RGD MGI:MGI:4950000 PMID:21262216 embryonic skeletal limb joint morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 endoderm formation ISO RGD:1550466 1624291 MGI:MGI:1858007|MGI:MGI:2148567|MGI:MGI:4418897 RGD MGI:MGI:3625553 more ... endodermal cell fate commitment ISO RGD:1550466 1624291 MGI:MGI:1858007|MGI:MGI:2148567 RGD MGI:MGI:3625553 PMID:12194849 endodermal cell fate commitment IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 endothelial tube morphogenesis ISO RGD:733705 1624291 RGD PMID:20123964 endothelial tube morphogenesis IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 endothelial tube morphogenesis ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 epithelial cell differentiation involved in prostate gland development ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:2667427 PMID:12813461 epithelial cell differentiation involved in prostate gland development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 epithelial tube branching involved in lung morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3773938 PMID:18231602 epithelial tube branching involved in lung morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 forebrain development ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2176173 RGD MGI:MGI:3529734 PMID:15708565 fungiform papilla formation ISO RGD:1550466 1624291 RGD MGI:MGI:3696593 PMID:17128274 fungiform papilla formation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 gastrulation with mouth forming second ISO RGD:1550466 1624291 MGI:MGI:1857678 RGD MGI:MGI:77405 PMID:8582267 gastrulation with mouth forming second IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 genitalia morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3807613 PMID:18635608 genitalia morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 glial cell fate determination ISO RGD:1550466 1624291 RGD MGI:MGI:3722716 PMID:17706960 glial cell fate determination IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 hair cycle process ISO RGD:1550466 1624291 MGI:MGI:2148594|MGI:MGI:2148596 RGD MGI:MGI:1934694 PMID:11371349 hair follicle morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2148594|MGI:MGI:2148596|MGI:MGI:5461544 RGD MGI:MGI:1934694 more ... hair follicle morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 hair follicle placode formation ISO RGD:1550466 1624291 MGI:MGI:1195272|MGI:MGI:2148594|MGI:MGI:2148596 RGD MGI:MGI:1934694 more ... hair follicle placode formation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 heart development ISO RGD:1550466 1624291 MGI:MGI:2148569 RGD MGI:MGI:2446944 PMID:12464179 hemopoiesis ISO RGD:1550466 1624291 RGD MGI:MGI:2662628 PMID:12717450 hindbrain development ISO RGD:1550466 1624291 RGD MGI:MGI:1931800 PMID:11262227 hindbrain development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 in utero embryonic development ISO RGD:1550466 1624291 MGI:MGI:1096327|MGI:MGI:2148567 RGD MGI:MGI:3773938 more ... in utero embryonic development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 kidney development ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3714576 PMID:17537789 layer formation in cerebral cortex ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3701617 RGD MGI:MGI:4454697 PMID:20503375 layer formation in cerebral cortex IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lens morphogenesis in camera-type eye ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3045749 RGD MGI:MGI:3603687 PMID:16102745 lens morphogenesis in camera-type eye IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 limb development ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:2450015 PMID:12569130 liver development IEP 1599633 RGD lung cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148569 RGD MGI:MGI:4361775 PMID:19805295 lung cell differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lung development ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2148594 RGD MGI:MGI:2677587 more ... lung induction ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2148569 RGD MGI:MGI:4360856 more ... lung induction IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lung-associated mesenchyme development ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3801531 PMID:18533146 lung-associated mesenchyme development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 male genitalia development ISO RGD:1550466 1624291 MGI:MGI:2148594 RGD MGI:MGI:3845460 PMID:19282366 male genitalia development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 mesenchymal cell proliferation involved in lung development ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3696593 more ... mesenchymal cell proliferation involved in lung development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 metanephros morphogenesis ISO RGD:1550466 1624291 RGD MGI:MGI:3821953 PMID:19060336 metanephros morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 midbrain development ISO RGD:1550466 1624291 RGD MGI:MGI:1931800 PMID:11262227 midbrain dopaminergic neuron differentiation ISO RGD:1550466 1624291 RGD MGI:MGI:3836885 PMID:19122665 midbrain dopaminergic neuron differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 midgut development IEP 2289844 RGD morphogenesis of embryonic epithelium ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3045749 RGD MGI:MGI:3603687 PMID:16102745 myoblast differentiation IEP 1599634 RGD negative regulation of angiogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of angiogenesis ISO RGD:1550466 1624291 RGD MGI:MGI:5883199 PMID:25961718 negative regulation of apoptotic signaling pathway ISO RGD:1550466 1624291 MGI:MGI:1858008|MGI:MGI:2148567|MGI:MGI:98957 RGD MGI:MGI:3051737 more ... negative regulation of apoptotic signaling pathway IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:2148591|MGI:MGI:2148594|MGI:MGI:2450929|MGI:MGI:3045749 RGD MGI:MGI:3578464 more ... negative regulation of cell proliferation ISO RGD:733705 1624291 RGD PMID:12970740 negative regulation of cell proliferation IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of cell proliferation ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 negative regulation of chondrocyte differentiation ISO RGD:1550466 1624291 MGI:MGI:2446084 RGD MGI:MGI:3701031 PMID:16818445 negative regulation of chondrocyte differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of gene expression ISO RGD:1550466 1624291 RGD MGI:MGI:3836885 PMID:19122665 negative regulation of gene expression IMP 13210526 PMID:23270756 BHF-UCL negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis ISO RGD:1550466 1624291 RGD MGI:MGI:3714576 PMID:17537789 negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of mitotic cell cycle, embryonic ISO RGD:1550466 1624291 RGD MGI:MGI:4941059 PMID:21325504 negative regulation of mitotic cell cycle, embryonic ISS UniProtKB:Q02248 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 negative regulation of mitotic cell cycle, embryonic IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of neuron death ISO RGD:1550466 1624291 MGI:MGI:2135607 RGD MGI:MGI:5437773 PMID:22956852 negative regulation of oligodendrocyte differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:4359141 PMID:19503085 negative regulation of oligodendrocyte differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of osteoclast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3041864 RGD MGI:MGI:3578468 PMID:15866165 negative regulation of osteoclast differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of oxidative stress-induced neuron death ISO RGD:1550466 1624291 RGD MGI:MGI:5770063 PMID:21752258 negative regulation of oxidative stress-induced neuron death IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein sumoylation ISO RGD:733705 1624291 RGD PMID:22155184 negative regulation of protein sumoylation IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein sumoylation ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 negative regulation of transcription by RNA polymerase II ISO RGD:1550466 1624291 RGD MGI:MGI:3613282 PMID:16040629 negative regulation of transcription by RNA polymerase II IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of transcription, DNA-templated ISO RGD:733705 1624291 RGD PMID:19653274 negative regulation of transcription, DNA-templated ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 negative regulation of transcription, DNA-templated ISO RGD:1550466 1624291 MGI:MGI:2148594 RGD MGI:MGI:2655026 more ... nephron tubule formation ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3714576 PMID:17537789 nephron tubule formation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 neural plate development ISO RGD:1550466 1624291 RGD MGI:MGI:5302997 PMID:22102609 neural plate development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron differentiation ISO RGD:1550466 1624291 RGD MGI:MGI:5689084 PMID:25009587 neuron migration ISO RGD:1550466 1624291 MGI:MGI:1334448 RGD MGI:MGI:5294271 PMID:21937711 neuron migration IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron projection extension ISO RGD:733705 1624291 RGD PMID:19830702 neuron projection extension IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron projection extension ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 odontogenesis of dentin-containing tooth IEP 2289810 RGD odontogenesis of dentin-containing tooth IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 odontogenesis of dentin-containing tooth ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3578468 PMID:15866165 oocyte development ISO RGD:1550466 1624291 MGI:MGI:98957 RGD MGI:MGI:4454604 PMID:20454446 oocyte development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 osteoclast differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3578468 PMID:15866165 osteoclast differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 oviduct development ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3042214 RGD MGI:MGI:3716048 PMID:17532316 oviduct development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 pancreas development ISO RGD:1550466 1624291 MGI:MGI:2148569 RGD MGI:MGI:3607950 PMID:16192304 pancreas development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of apoptotic process ISO RGD:733705 1624291 RGD PMID:12651860 PMID:12970740 positive regulation of apoptotic process ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 positive regulation of branching involved in lung morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3801531 PMID:18533146 positive regulation of cell proliferation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3577106 RGD MGI:MGI:4359548 PMID:19690384 positive regulation of chromatin-mediated maintenance of transcription ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 positive regulation of chromatin-mediated maintenance of transcription IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of core promoter binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of core promoter binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of core promoter binding ISO RGD:733705 1624291 RGD PMID:22723415 positive regulation of core promoter binding ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 positive regulation of determination of dorsal identity ISO RGD:1550466 1624291 RGD MGI:MGI:3797993 PMID:18316368 positive regulation of determination of dorsal identity IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of DNA binding transcription factor activity ISO RGD:1550466 1624291 RGD MGI:MGI:5700307 PMID:15905404 positive regulation of DNA binding transcription factor activity IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of DNA binding transcription factor activity IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of DNA binding transcription factor activity ISO RGD:733705 1624291 RGD PMID:15905404 positive regulation of DNA-templated transcription, initiation ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 positive regulation of DNA-templated transcription, initiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of endothelial cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3773938 PMID:18231602 positive regulation of endothelial cell differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of epithelial cell differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008|MGI:MGI:2445707|MGI:MGI:2679524 RGD MGI:MGI:3613282 PMID:16040629 positive regulation of epithelial cell proliferation involved in prostate gland development ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:2667427 PMID:12813461 positive regulation of epithelial cell proliferation involved in prostate gland development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of epithelial to mesenchymal transition ISO RGD:733705 1624291 UniProtKB:Q9NX18 RGD PMID:23983127 positive regulation of fibroblast growth factor receptor signaling pathway ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3773938 more ... positive regulation of fibroblast growth factor receptor signaling pathway IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gene expression ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3577106 RGD MGI:MGI:3773938 more ... positive regulation of heparan sulfate proteoglycan biosynthetic process ISO RGD:733705 1624291 RGD PMID:15853773 positive regulation of heparan sulfate proteoglycan biosynthetic process IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of heparan sulfate proteoglycan biosynthetic process ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 positive regulation of I-kappaB kinase/NF-kappaB signaling ISO RGD:1550466 1624291 RGD MGI:MGI:4355652 PMID:19619491 positive regulation of I-kappaB kinase/NF-kappaB signaling IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of MAPK cascade ISO RGD:1550466 1624291 MGI:MGI:88039 RGD MGI:MGI:3618985 PMID:16478791 positive regulation of MAPK cascade IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of mesenchymal cell proliferation ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3773938 more ... positive regulation of mesenchymal cell proliferation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of neuroblast proliferation ISO RGD:1550466 1624291 MGI:MGI:1334448 RGD MGI:MGI:4941059 more ... positive regulation of neuroblast proliferation ISS UniProtKB:Q02248 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 positive regulation of neuroblast proliferation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of neuron apoptotic process ISO RGD:733705 1624291 RGD PMID:19591802 positive regulation of neuron apoptotic process IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of osteoblast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148591|MGI:MGI:2148594|MGI:MGI:2450929 RGD MGI:MGI:3578464 PMID:15866163 positive regulation of osteoblast differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of skeletal muscle tissue development ISO RGD:1550466 1624291 RGD MGI:MGI:5619733 PMID:23460868 positive regulation of skeletal muscle tissue development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of telomerase activity ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 positive regulation of telomerase activity IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of telomere maintenance via telomerase ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 positive regulation of telomere maintenance via telomerase IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of transcription by RNA polymerase II ISO RGD:733705 1624291 RGD PMID:11751639 more ... positive regulation of transcription by RNA polymerase II IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of transcription by RNA polymerase II ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 positive regulation of transcription by RNA polymerase II IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of transcription by RNA polymerase II ISO RGD:1550466 1624291 MGI:MGI:104554|MGI:MGI:109330|MGI:MGI:1202879|MGI:MGI:97487|MGI:MGI:98358|UniProtKB:P27782 RGD MGI:MGI:3038034 more ... positive regulation of transcription, DNA-templated ISO RGD:733705 1624291 RGD PMID:12949260 more ... positive regulation of transcription, DNA-templated ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 positive regulation of transcription, DNA-templated ISO RGD:1550466 1624291 MGI:MGI:1858008|MGI:MGI:2148567|MGI:MGI:3577106 RGD MGI:MGI:1351293 more ... protein heterooligomerization IPI RGD:69280 RGD:1359485 2291902 RGD protein localization to cell surface ISO RGD:733705 1624291 RGD PMID:20086044 protein localization to cell surface IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein localization to cell surface ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 proximal/distal pattern formation ISO RGD:1550466 1624291 MGI:MGI:2148594 RGD MGI:MGI:2677587 PMID:12885771 proximal/distal pattern formation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of apoptotic process ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:4430000 PMID:20043884 regulation of calcium ion import ISO RGD:733705 1624291 RGD PMID:19996314 regulation of calcium ion import IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of calcium ion import ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 regulation of cell differentiation ISO RGD:1550466 1624291 RGD MGI:MGI:2662628 PMID:12717450 regulation of cell proliferation ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:2386811 more ... regulation of centriole-centriole cohesion ISO RGD:733705 1624291 RGD PMID:18086858 regulation of centriole-centriole cohesion IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of centriole-centriole cohesion ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 regulation of centromeric sister chromatid cohesion ISO RGD:1550466 1624291 RGD MGI:MGI:4835108 PMID:20300119 regulation of centromeric sister chromatid cohesion IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of centromeric sister chromatid cohesion ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 regulation of centromeric sister chromatid cohesion IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of centromeric sister chromatid cohesion ISO RGD:733705 1624291 RGD PMID:20300119 regulation of core promoter binding ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 regulation of epithelial cell differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:2667427 PMID:12813461 regulation of euchromatin binding ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 regulation of euchromatin binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of gene expression ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:5302997 PMID:22102609 regulation of myelination ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3849618 PMID:19515974 regulation of myelination IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of nephron tubule epithelial cell differentiation ISO RGD:1550466 1624291 RGD MGI:MGI:3822373 PMID:19112489 regulation of nephron tubule epithelial cell differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of osteoblast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3044412 RGD MGI:MGI:3511731 more ... regulation of osteoclast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3584206 PMID:15802266 regulation of protein localization to cell surface ISO RGD:733705 1624291 RGD PMID:19996314 regulation of protein localization to cell surface IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of protein localization to cell surface ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 regulation of secondary heart field cardioblast proliferation ISO RGD:1550466 1624291 RGD MGI:MGI:4438134 PMID:19620969 regulation of secondary heart field cardioblast proliferation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of smooth muscle cell proliferation ISO RGD:733705 1624291 RGD PMID:17122440 regulation of smooth muscle cell proliferation IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of smooth muscle cell proliferation ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 regulation of T cell proliferation ISO RGD:1550466 1624291 MGI:MGI:2148594|MGI:MGI:2448686 RGD MGI:MGI:2680853 PMID:14608382 regulation of T cell proliferation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of timing of anagen IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of timing of anagen ISO RGD:1550466 1624291 RGD MGI:MGI:5571208 PMID:24681597 regulation of transcription by RNA polymerase II ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:4430000 PMID:20043884 regulation of transcription, DNA-templated ISO RGD:1550466 1624291 RGD MGI:MGI:2386811 more ... renal inner medulla development ISO RGD:1550466 1624291 RGD MGI:MGI:3821953 PMID:19060336 renal inner medulla development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 renal outer medulla development ISO RGD:1550466 1624291 RGD MGI:MGI:3821953 PMID:19060336 renal outer medulla development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 renal system development ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3807613 PMID:18635608 renal vesicle formation ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3714576 PMID:17537789 renal vesicle formation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to activity IEP 10045362 RGD response to cadmium ion IEP 1598557 RGD response to cytokine IDA 2289841 RGD response to drug ISO RGD:733705 1624291 RGD PMID:18291362 response to estradiol IEP 10045362 RGD response to estradiol IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to estradiol ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 response to estradiol ISO RGD:733705 1624291 RGD PMID:15304487 response to estrogen IDA 1599635 RGD response to hormone IEP 2289842 RGD response to organic cyclic compound IEP 2289838 RGD Schwann cell proliferation IMP 2289839 RGD skeletal system development ISO RGD:1550466 1624291 MGI:MGI:2148591|MGI:MGI:2148594|MGI:MGI:2450929 RGD MGI:MGI:3578464 PMID:15866163 skin development ISO RGD:1550466 1624291 MGI:MGI:2148594 RGD MGI:MGI:4412144 PMID:19718027 smooth muscle cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567|MGI:MGI:3577106 RGD MGI:MGI:4359548 PMID:19690384 smooth muscle cell differentiation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 sympathetic ganglion development ISO RGD:1550466 1624291 RGD MGI:MGI:4941059 PMID:21325504 sympathetic ganglion development ISS UniProtKB:Q02248 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 sympathetic ganglion development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 synapse organization ISO RGD:1550466 1624291 MGI:MGI:2148594 RGD MGI:MGI:2680876 PMID:14622577 synapse organization IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 synaptic vesicle transport ISO RGD:1550466 1624291 MGI:MGI:2148594 RGD MGI:MGI:2680876 PMID:14622577 synaptic vesicle transport IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 T cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148594|MGI:MGI:2448686 RGD MGI:MGI:2680853 PMID:14608382 T cell differentiation in thymus ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3588595 PMID:16025118 T cell differentiation in thymus IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 thymus development ISO RGD:1550466 1624291 MGI:MGI:1858008 RGD MGI:MGI:3588595 PMID:16025118 thymus development IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 trachea formation ISO RGD:1550466 1624291 MGI:MGI:2148569 RGD MGI:MGI:4361775 PMID:19805295 trachea formation IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 trachea morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3773938 more ... transcription by RNA polymerase II IEA GO:0001105 1600115 GO_REF:0000108 GOC GO_REF:0000108 transcription, DNA-templated NAS 10395276 PMID:12610652 ARUK-UCL vasculature development ISO RGD:1550466 1624291 RGD MGI:MGI:3829282 PMID:19129494 vasculogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 RGD MGI:MGI:3773938 PMID:18231602 Cellular Component adherens junction ISO RGD:1550466 1624291 RGD MGI:MGI:2386380 more ... adherens junction ISO RGD:733705 1624291 RGD PMID:16858403 apical junction complex ISO RGD:1550466 1624291 RGD MGI:MGI:3610718 more ... apical part of cell ISO RGD:1550466 1624291 RGD MGI:MGI:3033551 more ... apical part of cell IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 basolateral plasma membrane ISO RGD:733705 1624291 RGD PMID:24862762 basolateral plasma membrane IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 basolateral plasma membrane IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 basolateral plasma membrane ISO RGD:1550466 1624291 RGD MGI:MGI:1331308 more ... beta-catenin destruction complex ISO RGD:1550466 1624291 RGD MGI:MGI:1336856 PMID:10318824 beta-catenin destruction complex IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 beta-catenin destruction complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 beta-catenin destruction complex IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 beta-catenin destruction complex ISO RGD:733705 1624291 RGD PMID:16188939 PMID:8638126 beta-catenin-TCF complex ISO RGD:1550466 1624291 RGD MGI:MGI:1196720 PMID:9488439 beta-catenin-TCF complex ISO RGD:733705 1624291 UniProtKB:O00512|UniProtKB:P15884|UniProtKB:Q9UJU2 RGD PMID:11955446 more ... beta-catenin-TCF7L2 complex ISO RGD:733705 1624291 RGD PMID:12651860 more ... beta-catenin-TCF7L2 complex IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 beta-catenin-TCF7L2 complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 bicellular tight junction ISO RGD:1550466 1624291 RGD MGI:MGI:3696284 PMID:17130295 bicellular tight junction IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 catenin complex ISO RGD:1550466 1624291 UniProtKB:P09803|UniProtKB:Q24298 RGD MGI:MGI:5882917 more ... catenin complex IBA PANTHER:PTN001153077 1600115 PAINT_REF:23315 GO_Central PAINT_REF:23315 catenin complex IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 catenin complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 catenin complex IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 catenin complex ISO RGD:733705 1624291 RGD PMID:18593713 more ... cell cortex ISO RGD:733705 1624291 RGD PMID:19038973 cell cortex IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell cortex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cell junction ISO RGD:733705 1624291 RGD PMID:19038973 PMID:20412773 cell junction ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cell periphery ISO RGD:733705 1624291 RGD PMID:19038973 cell periphery ISS UniProtKB:P35222 1600115 GO_REF:0000024 BHF-UCL GO_REF:0000024 cell projection membrane ISO RGD:1550466 1624291 RGD MGI:MGI:3689461 PMID:16621792 cell-cell adherens junction IDA 1626295 RGD cell-cell adherens junction ISO RGD:733705 1624291 RGD PMID:10403777 more ... cell-cell adherens junction ISO RGD:1550466 1624291 RGD MGI:MGI:2154851 more ... cell-cell adherens junction IDA 2291902 RGD cell-cell junction ISO RGD:12299678 1624291 RGD PMID:10873669 cell-cell junction ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cell-cell junction ISS UniProtKB:B6V8E6 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cell-cell junction ISO RGD:1550466 1624291 RGD MGI:MGI:1331308 more ... cell-cell junction ISO RGD:733705 1624291 RGD PMID:19151727 PMID:19996314 centrosome ISO RGD:1550466 1624291 RGD MGI:MGI:4835108 PMID:20300119 centrosome IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 centrosome ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 centrosome IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 centrosome ISO RGD:733705 1624291 RGD PMID:18086858 PMID:20300119 cytoplasm TAS 70260 RGD cytoplasm ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 cytoplasm IDA 10395276 PMID:12610652 ARUK-UCL cytoplasm ISO RGD:1550466 1624291 RGD MGI:MGI:2154850 more ... cytoplasm ISO RGD:733705 1624291 RGD PMID:11793365 more ... cytosol IDA 1599635 RGD cytosol IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytosol IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytosol ISO RGD:1550466 1624291 RGD MGI:MGI:2385552 more ... cytosol ISO RGD:733705 1624291 RGD PMID:10980594 PMID:19187541 dendritic shaft IDA 1299225 RGD exocytic vesicle ISO RGD:12299678 1624291 RGD PMID:18504258 fascia adherens ISO RGD:1550466 1624291 RGD MGI:MGI:3656458 PMID:16481394 fascia adherens IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 flotillin complex ISO RGD:1550466 1624291 RGD MGI:MGI:5634880 PMID:24046456 flotillin complex IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 intercalated disc ISO RGD:1550466 1624291 RGD MGI:MGI:3720394 PMID:17535849 intracellular ISO RGD:733705 1624291 RGD PMID:12651860 intracellular ISO RGD:1550466 1624291 RGD MGI:MGI:5882910 PMID:12651860 lamellipodium ISO RGD:1550466 1624291 RGD MGI:MGI:3028451 PMID:14657280 lamellipodium IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lateral plasma membrane ISO RGD:733705 1624291 RGD PMID:12072559 lateral plasma membrane IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lateral plasma membrane IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lateral plasma membrane ISO RGD:1550466 1624291 RGD MGI:MGI:3528104 PMID:15645444 membrane IDA 8553932 PMID:16815997 UniProtKB membrane ISO RGD:1550466 1624291 RGD MGI:MGI:2154850 more ... microvillus membrane ISO RGD:1550466 1624291 RGD MGI:MGI:3617131 PMID:16439479 microvillus membrane IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron projection colocalizes_with IDA 1599286 RGD nuclear euchromatin ISO RGD:733705 1624291 RGD PMID:22723415 nuclear euchromatin IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 nuclear euchromatin IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 nuclear euchromatin ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 nuclear membrane IDA 10395276 PMID:12610652 ARUK-UCL nuclear transcription factor complex ISO RGD:1550466 1624291 RGD MGI:MGI:5428344 PMID:22723415 nucleus IDA 1599635 RGD nucleus ISO RGD:733705 1624291 RGD PMID:10980594 more ... nucleus IDA 12790651 PMID:16805831 ARUK-UCL nucleus ISO RGD:1550466 1624291 RGD MGI:MGI:2154850 more ... perinuclear region of cytoplasm IDA 7242068 RGD perinuclear region of cytoplasm IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 perinuclear region of cytoplasm ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 perinuclear region of cytoplasm ISO RGD:733705 1624291 RGD PMID:19038973 plasma membrane ISO RGD:12299678 1624291 RGD PMID:8636221 plasma membrane ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 plasma membrane IDA 10395276 PMID:12610652 ARUK-UCL plasma membrane ISO RGD:1550466 1624291 RGD MGI:MGI:2180453 more ... plasma membrane ISO RGD:733705 1624291 RGD GO_REF:0000052 more ... protein-containing complex IDA 1626295 RGD protein-containing complex ISO RGD:733705 1624291 RGD PMID:22083958 protein-DNA complex ISO RGD:733705 1624291 RGD PMID:10825188 protein-DNA complex IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein-DNA complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 Scrib-APC-beta-catenin complex ISO RGD:1550466 1624291 RGD MGI:MGI:4362003 PMID:16611247 Scrib-APC-beta-catenin complex IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 spindle pole IEA UniProtKB-SubCell:SL-0448 1600115 GO_REF:0000039 UniProtKB GO_REF:0000039 synapse IDA 1299225 RGD synapse ISO RGD:1550466 1624291 RGD MGI:MGI:5608921 PMID:25232112 synapse IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 transcription factor complex ISO RGD:733705 1624291 RGD PMID:11751639 transcription factor complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 transcription factor complex ISO RGD:1550466 1624291 RGD MGI:MGI:2446944 more ... Wnt signalosome ISO RGD:1550466 1624291 RGD MGI:MGI:5440351 PMID:22899650 Wnt signalosome IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Z disc ISO RGD:1550466 1624291 RGD MGI:MGI:81460 PMID:8821035 Z disc IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Molecular Function alpha-catenin binding ISO RGD:1550466 1624291 UniProtKB:Q54MH2 RGD MGI:MGI:2447521 more ... alpha-catenin binding IBA PANTHER:PTN001153077 1600115 PAINT_REF:23315 GO_Central PAINT_REF:23315 alpha-catenin binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 alpha-catenin binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 alpha-catenin binding ISO RGD:733705 1624291 UniProtKB:P35221|UniProtKB:Q9UI47 RGD PMID:23136403 more ... cadherin binding IDA 1299225 RGD cadherin binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cadherin binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cadherin binding ISO RGD:733705 1624291 UniProtKB:P12830|UniProtKB:P33151|UniProtKB:Q86UP0-1|UniProtKB:Q86UP0-2 RGD PMID:12734196 more ... cadherin binding ISO RGD:1550466 1624291 UniProtKB:P09803|UniProtKB:Q24298 RGD MGI:MGI:3037401 more ... cadherin binding IPI RGD:69280 1626295 RGD cadherin binding IDA 70260 RGD chromatin binding ISO RGD:1550466 1624291 MGI:MGI:1202879 RGD MGI:MGI:3038034 more ... chromatin binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 disordered domain specific binding ISO RGD:1550466 1624291 UniProtKB:P09803|UniProtKB:Q24298 RGD MGI:MGI:5882917 PMID:11121423 disordered domain specific binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 DNA binding transcription factor activity ISO RGD:1550466 1624291 RGD MGI:MGI:2386811 PMID:12235125 DNA binding transcription factor activity IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 enzyme binding ISO RGD:733705 1624291 UniProtKB:Q13526|UniProtKB:Q9H3S7|UniProtKB:Q9UBN7 RGD PMID:11533658 more ... enzyme binding ISO RGD:1550466 1624291 UniProtKB:Q9QUR7 RGD MGI:MGI:5432836 PMID:22645310 estrogen receptor binding ISO RGD:733705 1624291 UniProtKB:P03372 RGD PMID:15304487 estrogen receptor binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 I-SMAD binding ISO RGD:733705 1624291 UniProtKB:O15105 RGD PMID:18593713 I-SMAD binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 ion channel binding ISO RGD:733705 1624291 UniProtKB:Q9UBN4 RGD PMID:19996314 ion channel binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 ionotropic glutamate receptor binding IPI RGD:2738 4107027 RGD kinase binding ISO RGD:733705 1624291 UniProtKB:P49841 RGD PMID:8638126 nitric-oxide synthase binding IPI RGD:3185 7777144 RGD nitric-oxide synthase binding IPI RGD:3186 7777144 RGD nuclear hormone receptor binding ISO RGD:733705 1624291 UniProtKB:P10275 RGD PMID:12799378 nuclear hormone receptor binding ISO RGD:1550466 1624291 UniProtKB:P51448 RGD MGI:MGI:2683830 PMID:14687547 protein binding IPI RGD:620241 1599635 RGD protein binding ISO RGD:733705 1624291 UniProtKB:A1Z199|UniProtKB:O00482-1|UniProtKB:O00512|UniProtKB:O14745|UniProtKB:O14746|UniProtKB:O15169|UniProtKB:O35625|UniProtKB:O43707|UniProtKB:O60907|UniProtKB:O70239|UniProtKB:O75564|UniProtKB:O95071|UniProtKB:P00519|UniProtKB:P08069|UniProtKB:P08575|UniProtKB:P10275|UniProtKB:P11362|UniProtKB:P11388|UniProtKB:P12830|UniProtKB:P12931|UniProtKB:P14618|UniProtKB:P14618-1|UniProtKB:P14923|UniProtKB:P15884|UniProtKB:P16284|UniProtKB:P17948|UniProtKB:P18012|UniProtKB:P18146|UniProtKB:P19022|UniProtKB:P19838|UniProtKB:P23470|UniProtKB:P23508|UniProtKB:P25054|UniProtKB:P26231|UniProtKB:P26358|UniProtKB:P27782|UniProtKB:P29317|UniProtKB:P29474|UniProtKB:P33151|UniProtKB:P33724|UniProtKB:P35221|UniProtKB:P36402|UniProtKB:P42858|UniProtKB:P46937|UniProtKB:P46937-3|UniProtKB:P46940|UniProtKB:P48431|UniProtKB:P49023|UniProtKB:P49757|UniProtKB:P49757-3|UniProtKB:P49768|UniProtKB:P49789|UniProtKB:P49841|UniProtKB:P50402|UniProtKB:P51955|UniProtKB:P55197|UniProtKB:P63208|UniProtKB:P78310|UniProtKB:Q01826|UniProtKB:Q01887|UniProtKB:Q03431|UniProtKB:Q04206|UniProtKB:Q08050|UniProtKB:Q12913|UniProtKB:Q13308|UniProtKB:Q13625|UniProtKB:Q13761|UniProtKB:Q14678|UniProtKB:Q15599|UniProtKB:Q15691|UniProtKB:Q2LD37|UniProtKB:Q5JTC6|UniProtKB:Q5T4T1|UniProtKB:Q5TZA2|UniProtKB:Q5VTB9|UniProtKB:Q6P1J9|UniProtKB:Q86VW0|UniProtKB:Q8TEK3|UniProtKB:Q8TEW0|UniProtKB:Q8WVC0|UniProtKB:Q8WY41|UniProtKB:Q92597|UniProtKB:Q92793|UniProtKB:Q96AC1|UniProtKB:Q99697|UniProtKB:Q99966|UniProtKB:Q9BZE0|UniProtKB:Q9BZK7|UniProtKB:Q9EPK5|UniProtKB:Q9GZQ8|UniProtKB:Q9GZV5|UniProtKB:Q9H6I2|UniProtKB:Q9HBB8|UniProtKB:Q9JHQ5|UniProtKB:Q9NQB0|UniProtKB:Q9NSA3|UniProtKB:Q9NYF0|UniProtKB:Q9UI47|UniProtKB:Q9UJU2|UniProtKB:Q9UKB1|UniProtKB:Q9UKB5|UniProtKB:Q9UKE5|UniProtKB:Q9UQB3|UniProtKB:Q9Y265|UniProtKB:Q9Y297|UniProtKB:Q9Y2T1|UniProtKB:Q9Y3M2|UniProtKB:Q9YGY0 RGD PMID:10773885 more ... protein binding ISO RGD:1550466 1624291 UniProtKB:E9Q9R9|UniProtKB:F1MSG6|UniProtKB:O15047|UniProtKB:O15169|UniProtKB:O35625|UniProtKB:O54826|UniProtKB:O88566|UniProtKB:P09803|UniProtKB:P15116|UniProtKB:P19785|UniProtKB:P25054|UniProtKB:P26231|UniProtKB:P27782|UniProtKB:P30999|UniProtKB:P33148|UniProtKB:P42859|UniProtKB:P45481|UniProtKB:P46662|UniProtKB:P46938|UniProtKB:P48432|UniProtKB:P49768|UniProtKB:P49841|UniProtKB:P60766|UniProtKB:P70188|UniProtKB:P97458|UniProtKB:P97792|UniProtKB:Q02248|UniProtKB:Q04207|UniProtKB:Q04887|UniProtKB:Q09472|UniProtKB:Q5NCY0|UniProtKB:Q60722|UniProtKB:Q60737|UniProtKB:Q61315|UniProtKB:Q61473|UniProtKB:Q61771|UniProtKB:Q65CL1|UniProtKB:Q67FY2|UniProtKB:Q6RHR9|UniProtKB:Q80U72|UniProtKB:Q924A0|UniProtKB:Q9D0S4|UniProtKB:Q9D219|UniProtKB:Q9DBG9|UniProtKB:Q9EPK8|UniProtKB:Q9JJN6|UniProtKB:Q9NQB0|UniProtKB:Q9NSA3|UniProtKB:Q9UJU2|UniProtKB:Q9WV60|UniProtKB:Q9Z1J1 RGD MGI:MGI:1196720 more ... protein binding IPI UniProtKB:O88382 70405 PMID:11826105 IntAct protein binding IPI UniProtKB:O88382 11041005 PMID:10080919 IntAct protein binding IPI UniProtKB:Q9WU10 8554288 PMID:16682528 UniProtKB protein binding IPI UniProtKB:P61810 8554317 PMID:10753743 UniProtKB protein binding IPI UniProtKB:P49841 632259 PMID:9482734 BHF-UCL protein binding IPI UniProtKB:O70239 4108508 PMID:10330181 BHF-UCL protein binding IPI RGD:1583309 2317776 RGD protein binding ISO RGD:12299678 1624291 UniProtKB:F1PBJ0|UniProtKB:O97758|UniProtKB:Q95LE0 RGD PMID:10873669 PMID:8636221 protein binding IPI RGD:3169 1599271 RGD protein C-terminus binding ISO RGD:733705 1624291 UniProtKB:P25054|UniProtKB:Q09472 RGD PMID:10773885 PMID:15843474 protein C-terminus binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein heterodimerization activity ISO RGD:1550466 1624291 RGD MGI:MGI:82531 PMID:8853988 protein heterodimerization activity IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein kinase binding ISO RGD:1550466 1624291 UniProtKB:Q5S006 RGD MGI:MGI:5440351 PMID:22899650 protein kinase binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein phosphatase binding ISO RGD:733705 1624291 UniProtKB:Q15262|UniProtKB:Q92729 RGD PMID:16574648 PMID:8663237 protein phosphatase binding IBA PANTHER:PTN001153077 1600115 PAINT_REF:23315 GO_Central PAINT_REF:23315 protein phosphatase binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein phosphatase binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein phosphatase binding ISO RGD:1550466 1624291 UniProtKB:O14522 RGD MGI:MGI:3689290 PMID:16973135 protein-containing complex binding IPI RGD:620829 RGD:69280 2313226 RGD repressing transcription factor binding ISO RGD:1550466 1624291 UniProtKB:P10071 RGD MGI:MGI:3709704 PMID:17331723 repressing transcription factor binding IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II activating transcription factor binding ISO RGD:733705 1624291 UniProtKB:Q9NQB0 RGD PMID:19443654 RNA polymerase II activating transcription factor binding IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II transcription coactivator activity IEA UniProtKB:Q02248|ensembl:ENSMUSP00000007130 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II transcription coactivator activity IEA UniProtKB:P35222|ensembl:ENSP00000495360 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II transcription coactivator activity ISO RGD:1550466 1624291 RGD MGI:MGI:2386811 more ... RNA polymerase II transcription coactivator activity ISO RGD:733705 1624291 RGD PMID:18193033 RNA polymerase II transcription factor binding ISO RGD:1550466 1624291 RGD MGI:MGI:3690195 more ... RNA polymerase II transcription factor binding ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 RNA polymerase II transcription factor binding ISO RGD:733705 1624291 UniProtKB:Q9UJU2 RGD PMID:12651860 more ... signal transducer activity IEA InterPro:IPR013284 1600115 GO_REF:0000002 InterPro GO_REF:0000002 SMAD binding ISO RGD:733705 1624291 UniProtKB:O15105 RGD PMID:18593713 transcription coactivator activity ISO RGD:733705 1624291 RGD PMID:11751639 more ... transcription coactivator activity ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProtKB GO_REF:0000024 transcription coactivator activity ISO RGD:1550466 1624291 RGD MGI:MGI:2446944 more ... transcription factor binding ISO RGD:1550466 1624291 MGI:MGI:109330|UniProtKB:Q60793 RGD MGI:MGI:3690195 more ... transcription factor binding ISO RGD:733705 1624291 UniProtKB:O43524|UniProtKB:Q9UJU2 RGD PMID:15905404 PMID:20123964
Gene-Chemical Interaction Annotations